# Chapter 99: Alcohol Withdrawal

Here is the comprehensive academic chapter on the biological and neurological basis of Alcohol Withdrawal, written according to all instructions and citing exclusively from the provided list of 2000 research papers.

# Chapter: The Biological and Neurological Basis of Alcohol Withdrawal

## Introduction

Alcohol withdrawal syndrome (AWS) is a complex and potentially life-threatening condition that emerges following the abrupt cessation or significant reduction of alcohol consumption in individuals with alcohol dependence (Saitz, 1998; Fair & Akwe, 2015; Venkateswarlu, 2016). This syndrome is not merely a psychological reaction but is rooted in profound neurobiological adaptations that occur in the central nervous system (CNS) in response to chronic, heavy alcohol use (Yersin, 1999; Hemmingsen et al., 1983). When alcohol, a potent CNS depressant, is suddenly removed, the brain enters a state of severe hyperexcitability, giving rise to a predictable constellation of signs and symptoms (Becker & Redmond, 2002; Yersin, 1999). Understanding the biological and neurological underpinnings of this syndrome is critical for predicting its severity, preventing complications, and developing effective treatments (Saitz, 1998; Unknown, 2007).

The clinical manifestations of AWS represent a spectrum of severity, ranging from mild anxiety and tremors to severe, life-threatening complications such as generalized tonic-clonic seizures, hallucinations, and delirium tremens (Saitz, 1998; Thompson & Weber, 2021; Madhavan, 2017). Symptoms typically begin within 6 to 24 hours after the last drink and can include autonomic hyperactivity (e.g., tachycardia, hypertension, diaphoresis), psychomotor agitation, insomnia, nausea, and anxiety (López et al., 2012; Riddle et al., 2010; Muncie et al., 2013). The most severe form, delirium tremens, is a medical emergency characterized by profound confusion, disorientation, hallucinations, and severe autonomic instability, carrying a significant risk of mortality if left untreated (Riddle et al., 2010; Strel'chuk, 1983; Aubin Hj et al., 1993).

From a biological perspective, AWS is the direct consequence of the brain's attempt to maintain homeostasis in the persistent presence of ethanol (Hemmingsen et al., 1983; Yersin, 1999). Chronic alcohol exposure forces the CNS to adapt by downregulating inhibitory neurotransmitter systems and upregulating excitatory ones to counteract alcohol's depressant effects (Alfonso‐Loeches & Guerri, 2011; Riddle et al., 2010). The abrupt removal of alcohol unmasks these compensatory changes, leading to a state of unopposed neuronal hyperexcitability that drives the clinical syndrome (Becker & Redmond, 2002; Hemmingsen & Kramp, 1988). Perturbations in γ-aminobutyric acid (GABA)-ergic and glutamatergic transmission are central to this process (Yarlagadda et al., 2007; Zutshi et al., 2007; Kašpárek et al., 2014).

This chapter will provide a comprehensive examination of the biological and neurological basis of alcohol withdrawal. It will delve into the critical roles of major neurotransmitter systems, exploring the neuropharmacological adaptations that precipitate the withdrawal state. We will discuss the specific brain regions and neural circuits implicated in the syndrome, drawing upon evidence from neuroimaging and electrophysiological studies (Lanièpce et al., 2020). The chapter will also cover the genetic and molecular factors that confer vulnerability to severe withdrawal, the cellular and synaptic mechanisms of neuroplasticity involved, and the biological rationale for current and emerging treatments. By synthesizing evidence from a wide array of clinical and preclinical research, this chapter aims to construct a detailed, multilevel understanding of the pathophysiology of alcohol withdrawal, from molecular changes to complex behavioral manifestations.

## Neurobiological Systems

The clinical presentation of alcohol withdrawal syndrome is a direct manifestation of widespread dysregulation across multiple neurobiological systems. Chronic alcohol consumption forces the brain to make profound neuroadaptive changes to counteract the substance's depressant effects, fundamentally altering the balance of neurotransmission (Hemmingsen et al., 1983; Alfonso‐Loeches & Guerri, 2011). When alcohol is withdrawn, this delicate, albeit pathological, homeostasis is shattered, resulting in a state of severe CNS hyperexcitability (Yersin, 1999; Becker & Redmond, 2002). This section details the key neurotransmitter systems and pathways implicated in the pathophysiology of AWS.

### The GABA/Glutamate Imbalance: A State of Hyperexcitability

The core neurobiological feature of alcohol withdrawal is a profound imbalance between the brain's primary inhibitory and excitatory systems, governed by γ-aminobutyric acid (GABA) and glutamate, respectively (Yarlagadda et al., 2007; Zutshi et al., 2007). Alcohol acutely enhances the function of GABA at the GABA-A receptor complex, which is a chloride ion channel (Riddle et al., 2010; Alfonso‐Loeches & Guerri, 2011). This action increases chloride influx, hyperpolarizes the neuronal membrane, and leads to neuronal inhibition, producing the sedative, anxiolytic, and motor-incoordinating effects of intoxication (Fair & Akwe, 2015; Riddle et al., 2010). In response to chronic alcohol exposure, the brain compensates by downregulating the number and function of GABA-A receptors to maintain a normal level of neuronal firing (Riddle et al., 2010). This neuroadaptation is a key component of tolerance development (Meier Pj, 1985).

Concurrently, alcohol acutely inhibits the function of the N-methyl-D-aspartate (NMDA) receptor, a subtype of glutamate receptor that mediates excitatory neurotransmission by regulating calcium influx into neurons (Fair & Akwe, 2015; Alfonso‐Loeches & Guerri, 2011). To counteract this chronic inhibition, the brain upregulates the number and sensitivity of NMDA receptors, creating a latent state of hyperexcitability (Becker & Redmond, 2002; Riddle et al., 2010).

Upon cessation of drinking, this carefully balanced system collapses. The inhibitory effect of alcohol on NMDA receptors is removed, unmasking the upregulated excitatory system and leading to excessive glutamate activity (Kašpárek et al., 2014). Simultaneously, the enhancing effect of alcohol at GABA-A receptors is lost, and the downregulated inhibitory system is insufficient to counterbalance the excitatory surge (Riddle et al., 2010). This dual-pronged failure—insufficient GABAergic inhibition and excessive glutamatergic excitation—results in global neuronal hyperexcitability (Hemmingsen & Kramp, 1988). This state is the direct neurochemical substrate for many of the cardinal symptoms of withdrawal, including anxiety, irritability, agitation, tremors, and, in its most severe form, generalized tonic-clonic seizures (Saitz, 1998; López et al., 2012; Becker & Redmond, 2002). The excitotoxicity resulting from excessive glutamate activity is also believed to contribute to alcohol-related brain damage (Pujol & Puel, 1999; Alfonso‐Loeches & Guerri, 2011).

### The Dopaminergic System: Dysphoria and Craving

The mesocorticolimbic dopamine system, often termed the brain's "reward pathway," is critically involved in the reinforcing effects of alcohol and other drugs of abuse (Huang & Tsai, 2012; Snyder, 2019). Acute alcohol consumption increases dopamine release, contributing to feelings of euphoria and pleasure (Snyder, 2019; Ashok, 2017). However, chronic alcohol use leads to significant neuroadaptations within this system, resulting in a state of reward hypofunction during withdrawal (Vendruscolo & Koob, 2019).

During the withdrawal/negative affect stage of the addiction cycle, the brain's stress systems are sensitized while the reward system is impaired (Vendruscolo & Koob, 2019; Wand, 2008). This leads to a profound negative emotional state characterized by dysphoria, anhedonia (the inability to experience pleasure), anxiety, and irritability (Saitz, 1998; Vendruscolo & Koob, 2019). These symptoms are not merely psychological reactions but are driven by a blunted dopaminergic response (Vendruscolo & Koob, 2019). This hypodopaminergic state contributes significantly to the psychological discomfort of withdrawal (Hayne & Louks, 1991).

Furthermore, this reward deficit is a powerful motivator for relapse (Spanagel, 2003; Daley & Douaihy, 2006). The intense desire for alcohol, or craving, that characterizes withdrawal is mediated by brain activation in regions like the amygdala and is driven, in part, by an attempt to alleviate the negative emotional state and restore the blunted reward function (Daley & Douaihy, 2019; Sosin et al., 2021). Thus, the dopaminergic system's dysregulation during withdrawal is central to both the affective symptoms (dysphoria, anhedonia) and the powerful motivational drive (craving) to resume drinking (Spanagel, 2003; Pelc, 1997).

### Autonomic and Noradrenergic Hyperactivity

A hallmark of AWS is marked autonomic hyperactivity, which manifests clinically as tachycardia, hypertension, diaphoresis (sweating), tremor, and hyperthermia (Saitz, 1998; López et al., 2012; Farooq et al., 2019). These signs are driven by a hyperadrenergic state resulting from overactivity of the sympathetic nervous system and central noradrenergic pathways (Yersin, 1999; Riddle et al., 2010; Benarroch, 2014).

Chronic alcohol use suppresses the activity of central noradrenergic neurons, particularly in the locus coeruleus, a key brainstem nucleus involved in arousal and the stress response (Hemmingsen et al., 1983). The brain compensates by increasing the firing rate and sensitivity of these neurons. Upon alcohol withdrawal, this compensatory hyperactivity is unleashed, leading to a massive release of catecholamines (Riddle et al., 2010; Boettger et al., 2006). This central noradrenergic surge drives the peripheral sympathetic overactivity, resulting in the characteristic cardiovascular and thermoregulatory signs of withdrawal (Benarroch, 2014; Hou & Rabchevsky, 2014). The increased adrenergic activity also contributes to psychological symptoms such as anxiety, agitation, restlessness, and insomnia (Saitz, 1998; Muncie et al., 2013). This state of autonomic instability can be life-threatening, contributing to cardiac arrhythmias and other cardiovascular complications (Benarroch, 2014; Hou & Rabchevsky, 2014). Studies have demonstrated a reduced baroreflex sensitivity during acute AWS, further highlighting the profound dysregulation of cardiovascular control (Boettger et al., 2006).

### Serotonergic and Endorphin System Dysregulation

The serotonin (5-HT) system is broadly involved in regulating mood, sleep, and anxiety, and its dysregulation is implicated in both depression and anxiety disorders (Scotton et al., 2019; Sarris et al., 2014). Given the high prevalence of anxiety and depressive symptoms during alcohol withdrawal, it is plausible that alterations in serotonergic neurotransmission contribute to this affective symptomatology (Pary et al., 1988; Malka, 1988). While direct evidence from the provided sources is limited, the clinical overlap between AWS and primary mood and anxiety disorders suggests a shared neurobiological substrate (Shivani et al., 2002). For instance, symptoms such as insomnia, irritability, and anxiety are common to both AWS and generalized anxiety disorder (Munir & Takov, 2021; Szkodny et al., 2014). Furthermore, the use of serotonergic agents can precipitate complex neuropsychiatric syndromes, indicating the system's sensitivity to pharmacological perturbation (Scotton et al., 2019).

The endogenous opioid system, which includes endorphins, is involved in pain modulation and the experience of pleasure (Arbuck, 2022). Alcohol consumption can stimulate this system, contributing to its euphoric effects (Ashok, 2017). Chronic use may lead to neuroadaptive changes, and withdrawal could plausibly involve an endorphin-deficient state, contributing to dysphoria and potentially to the heightened pain sensitivity sometimes reported during withdrawal (Arbuck, 2022). This dysregulation may also play a role in the high rates of comorbid opioid use disorders seen in individuals with alcohol dependence (Stohler et al., 1993).

In summary, the neurobiology of alcohol withdrawal is characterized by a multi-system failure of homeostasis. The primary driver is a severe imbalance between GABAergic and glutamatergic systems, creating a state of CNS hyperexcitability. This is compounded by a hypofunctional dopaminergic reward system, leading to dysphoria and craving, and a hyperfunctional noradrenergic stress system, producing dangerous autonomic instability. These core disturbances orchestrate the complex and multifaceted clinical presentation of AWS.

## Genetic and Molecular Basis

The clinical expression and severity of alcohol withdrawal syndrome vary considerably among individuals, suggesting the influence of underlying genetic and molecular factors (Madhavan, 2017). While environmental variables such as the duration and quantity of alcohol consumption are crucial determinants of dependence and withdrawal severity (Riddle et al., 2010; Madhavan, 2017), a substantial body of evidence points toward a significant heritable component that predisposes individuals to both alcohol dependence and a more severe withdrawal course (Kosobud & Crabbe, 1995). This section explores the genetic contributions to AWS and the molecular mechanisms, such as kindling, that underpin the progressive intensification of withdrawal symptoms.

### Heritability and Genetic Factors

Clinical observations frequently note a positive family history of alcohol dependence in patients presenting with AWS (Yarlagadda et al., 2007; Zutshi et al., 2007). Family, twin, and adoption studies have consistently demonstrated that the risk for developing an alcohol use disorder is influenced by genetic factors, with heritability estimates suggesting a significant genetic variance in risk (DiMartini, 2007). This genetic predisposition likely extends to the development of physical dependence and the severity of the subsequent withdrawal syndrome (Kosobud & Crabbe, 1995). Indeed, research in animal models has been instrumental in identifying genetic influences on the development of physical dependence and the intensity of withdrawal reactions (Kosobud & Crabbe, 1995). These studies suggest that specific genetic variations may affect the neurochemical systems most perturbed by chronic alcohol use, such as the GABA-A and NMDA receptor systems, thereby modulating an individual's vulnerability to developing severe withdrawal symptoms (Alfonso‐Loeches & Guerri, 2011).

While specific susceptibility genes have not been definitively identified from the provided literature, the concept of a genetic predisposition is well-supported (Pelc, 1980; DiMartini, 2007). This predisposition may manifest as a constitutional tendency toward the biochemical reactions that favor excessive drinking and the development of dependence (Echeverria, 1881; Davies, 2023). It is plausible that genetic polymorphisms in genes coding for neurotransmitter receptors, transporters, or metabolic enzymes could create a biological vulnerability that, when combined with environmental stressors and chronic alcohol exposure, culminates in a more severe withdrawal phenotype (Anisman & Merali, 1999; Goodyer et al., 2000). The heterogeneity of alcoholism, as conceptualized in Jellinek's typology, may also reflect different underlying genetic vulnerabilities that influence patterns of drinking and the nature of the withdrawal syndrome (Borowski, 2013).

### Molecular Mechanisms and the Kindling Hypothesis

One of the most clinically significant and biologically intriguing aspects of AWS is the phenomenon of kindling, which provides a molecular framework for understanding the progressive worsening of symptoms over successive withdrawal episodes (Becker, 1998). Kindling is a process of neuronal plasticity in which repeated, sub-threshold stimulation of the brain eventually leads to the development of full-blown seizures (Becker, 1998; Pontius, 1993). In the context of alcoholism, each episode of alcohol withdrawal can be conceptualized as a "chemical stimulus" that kindles the brain, lowering the seizure threshold and increasing the severity of subsequent withdrawal syndromes (Becker, 1998; Becker & Redmond, 2002).

This hypothesis is supported by clinical observations that patients with a history of multiple detoxifications often experience more severe withdrawal, including a higher risk of seizures and delirium tremens, compared to their first withdrawal episode (Saitz, 1998; Becker, 1998). The molecular mechanisms underlying this kindling process are thought to involve long-lasting neuroadaptive changes in the glutamatergic system, particularly involving the NMDA receptor (Becker & Redmond, 2002). Repeated cycles of alcohol intoxication and withdrawal lead to a persistent state of NMDA receptor hyperexcitability, making the brain progressively more susceptible to the uncontrolled neuronal firing that characterizes withdrawal seizures (Becker, 1998). This process represents a form of long-term potentiation, a fundamental mechanism of synaptic plasticity and memory, suggesting that the brain "learns" to have more severe withdrawals over time (Alfonso‐Loeches & Guerri, 2011).

The development of CNS hyperexcitability is a cumulative process (Hemmingsen & Kramp, 1988), and kindling provides a plausible molecular basis for this accumulation. This progressive sensitization helps explain why withdrawal seizures can appear after many years of alcoholism (Strel'chuk, 1983) and why the severity of withdrawal seems to intensify over the course of an individual's drinking history (Becker, 1998). The phenomenon of kindling underscores the importance of aggressive medical management even for mild withdrawal episodes, as preventing the full expression of withdrawal may mitigate the neuroplastic changes that lead to more severe future episodes (Saitz, 1998; Becker, 1998).

Other molecular pathways are also implicated. Chronic alcohol use and withdrawal are considered significant stressors that activate the hypothalamic-pituitary-adrenal (HPA) axis and other stress-response systems (Wand, 2008; Vendruscolo & Koob, 2019). The hormones and signaling molecules released during stress, such as corticotropin-releasing factor (CRF) and glucocorticoids, can modulate the same neural circuits involved in withdrawal, potentially exacerbating hyperexcitability and negative affective states (Wand, 2008). Furthermore, alcohol withdrawal is associated with changes in membrane excitability and the function of synaptic proteins and phospholipids, which may contribute to the development of CNS hyperexcitability (Hemmingsen & Kramp, 1988). Receptor plasticity, particularly the downregulation of GABA-A receptors and upregulation of NMDA receptors, remains the central molecular adaptation driving the withdrawal state (Riddle et al., 2010; Joshi & Kapur, 2012).

In conclusion, the biological basis of alcohol withdrawal is shaped by a complex interplay of genetic predispositions and acquired molecular changes. A heritable component likely influences an individual's susceptibility to dependence and the severity of withdrawal. At the molecular level, the kindling hypothesis offers a powerful explanation for the progressive nature of the syndrome, implicating long-term neuroplastic changes in the glutamatergic system. These mechanisms, combined with chronic stress system activation and widespread receptor plasticity, create a state of profound and escalating neuronal hyperexcitability that defines the neurobiology of alcohol withdrawal.

## Brain Structure and Function

Alcohol withdrawal syndrome manifests through a complex interplay of altered functions across various brain regions and neural circuits. While the primary drivers are neurochemical imbalances, these disturbances have distinct anatomical and functional correlates (Alfonso‐Loeches & Guerri, 2011). The symptoms of AWS, from cognitive deficits and emotional lability to seizures and autonomic storm, can be mapped onto specific brain networks that become profoundly dysfunctional upon alcohol cessation. Neuroimaging and electrophysiological studies, although limited in the provided literature, offer valuable insights into these structural and functional changes.

### Implicated Brain Regions and Neural Circuits

The widespread effects of chronic alcohol use and subsequent withdrawal suggest that multiple brain regions are involved (Page, 1983; Slobodin & Odeh, 2015). The clinical picture of AWS points to significant disruption within limbic and cortical circuits.

**Limbic System (Hippocampus and Amygdala):** The limbic system is central to memory, emotion, and motivation, and its dysfunction is prominent during AWS. The hippocampus, critical for memory formation, is particularly vulnerable to the effects of alcohol (Alfonso‐Loeches & Guerri, 2011; Rose & Grant, 2010). Cognitive impairments, especially deficits in short-term memory and learning, are well-documented findings in individuals with a history of alcohol abuse and during withdrawal (Page, 1983; Bernardin et al., 2014; Rose & Grant, 2010). These deficits point directly to hippocampal dysfunction (Squire, 1989). Furthermore, the hippocampus is a region with a low seizure threshold, and its hyperexcitability during withdrawal is a likely substrate for withdrawal-related seizures (Becker, 1998; Farrell et al., 2016). Post-seizure hypoperfusion and hypoxia have been observed specifically in the hippocampus, which could contribute to further neuronal damage and cognitive impairment (Farrell et al., 2016; Unknown, 2016).

The amygdala, a key node in the processing of fear and anxiety, is also profoundly affected (Vendruscolo & Koob, 2019). The heightened anxiety, irritability, and fear that characterize AWS are strongly linked to hyperactivity within the extended amygdala, a circuit that integrates stress and reward processing (Daley & Douaihy, 2019; Vendruscolo & Koob, 2019). This limbic hyperactivity, driven by the GABA/glutamate imbalance, contributes to the powerful negative emotional state of withdrawal (Kryzhanovskiĭ Gn & Rodina Vi, 1987).

**Prefrontal Cortex (PFC):** The PFC is responsible for executive functions, including planning, decision-making, impulse control, and the regulation of emotion and behavior (Bernardin et al., 2014). Chronic alcohol use is known to cause structural and functional damage to the frontal lobes (Slobodin & Odeh, 2015; Leong et al., 2022). During withdrawal, deficits in executive function, such as impaired judgment, difficulty concentrating, and impulsivity, are common (Page, 1983; Smith et al., 2002). This PFC dysfunction not only contributes to the cognitive symptoms of withdrawal but also impairs the individual's ability to resist cravings and manage the impulse to drink, thereby increasing the risk of relapse (Huang & Tsai, 2012; Vendruscolo & Koob, 2019). The disinhibition and poor impulse control seen in withdrawal reflect a breakdown in the top-down regulatory control exerted by the PFC over limbic structures (Batinić et al., 2017).

**Cerebellum and Basal Ganglia:** Motor symptoms such as tremor and ataxia (incoordination) are cardinal signs of AWS (Saitz, 1998; Solovov, 1995). These symptoms point to dysfunction in motor control circuits involving the cerebellum and basal ganglia (Page, 1983). The cerebellum is known to be particularly vulnerable to the toxic effects of alcohol, and its dysfunction contributes to the gait and balance problems seen during both intoxication and withdrawal (Slobodin & Odeh, 2015). The basal ganglia, integral to the reward system, are also implicated in the compulsive drug-seeking behaviors and motor restlessness of withdrawal (Vendruscolo & Koob, 2019; Riddle et al., 2010).

**Brainstem:** The brainstem, particularly the locus coeruleus and reticular activating system, is the source of the autonomic hyperactivity seen in AWS (Hemmingsen et al., 1983; de Castro, 2008). The profound release of norepinephrine from this region drives the tachycardia, hypertension, and other signs of sympathetic storm (Benarroch, 2014). This brainstem hyperexcitability also contributes to sleep disturbances and hyperarousal (Yersin, 1999).

### Neuroimaging and Electrophysiological Findings

Neuroimaging provides a window into the structural and functional brain changes associated with chronic alcohol use and withdrawal.

**Structural Imaging (CT and MRI):** Chronic heavy alcohol use is associated with significant structural brain changes, including generalized brain atrophy, ventricular enlargement, and sulcal widening, which are visible on CT or MRI scans (Slobodin & Odeh, 2015; Page, 1983). The frontal lobes appear to be particularly vulnerable to this alcohol-related brain damage (Slobodin & Odeh, 2015). A key study by Lanièpce et al. (2020) directly linked the severity of AWS to structural brain alterations in early abstinence. Using MRI, they found that patients with a history of moderate AWS exhibited widespread grey matter shrinkage, particularly in fronto-insular and thalamus/hypothalamus regions, compared to patients with mild AWS and healthy controls. This provides direct evidence that the neurotoxic events occurring during withdrawal contribute to measurable brain volume loss. These structural changes likely form the substrate for the persistent cognitive deficits observed even after acute withdrawal symptoms have subsided (Bernardin et al., 2014).

**Functional Imaging and Blood Flow:** Functional imaging studies can reveal abnormalities in brain activity and perfusion. Delirium tremens is associated with cerebral hyperexcitability, which corresponds to findings of increased cerebral blood flow in some studies (Hemmingsen & Kramp, 1988). However, the period following withdrawal seizures is often characterized by hypoperfusion (reduced blood flow) and hypoxia in the affected brain regions (Farrell et al., 2016; Unknown, 2016). This postictal hypoperfusion, which can last for over an hour, may represent a "stroke-like event" that contributes to neuronal injury and the transient neurological deficits (like memory impairment or motor weakness) sometimes seen after seizures (Farrell et al., 2016). This finding highlights the potential for withdrawal seizures to cause secondary ischemic damage.

**Electroencephalography (EEG):** The EEG is a critical tool for assessing brain function during AWS, particularly for diagnosing seizures and delirium (Yersin, 1999). During withdrawal, the EEG may show a pattern of generalized slowing, reflecting encephalopathy, or it may reveal epileptiform abnormalities (Bassetti & Karbowski, 1990; Banoczi, 2005). The presence of paroxysmal activity can indicate a lowered seizure threshold (Duncan, 1988). In cases of non-convulsive status epilepticus, which can present as a prolonged confusional state during withdrawal, the EEG is essential for diagnosis, showing continuous or rapidly recurring seizure activity (Ferlazzo, 2010; Fernández Torre et al., 2003). The EEG can also demonstrate abnormalities related to sleep architecture disruption, a core feature of AWS (Lanièpce et al., 2020). Polysomnography in patients with a history of moderate AWS reveals significant non-rapid eye movement (NREM) sleep alterations, including a lower percentage of slow-wave sleep, which is critical for brain restoration (Lanièpce et al., 2020).

In summary, alcohol withdrawal is a whole-brain phenomenon. The hyperexcitable neurochemical state translates into dysfunctional activity across a network of brain regions, including the limbic system, prefrontal cortex, cerebellum, and brainstem. Structural imaging confirms that severe withdrawal is associated with grey matter volume loss, while functional and electrophysiological studies reveal patterns of hyperexcitability, post-seizure hypoperfusion, and profound sleep architecture disruption, providing a multi-modal picture of brain dysfunction in AWS.

## Developmental Neurobiology

The impact of alcohol on the brain is not uniform across the lifespan; developmental stage is a critical variable that modulates both the vulnerability to alcohol's effects and the clinical presentation of its withdrawal (Alfonso‐Loeches & Guerri, 2011). Exposure to alcohol during critical periods of brain development, from gestation through adolescence, can have profound and lasting consequences, potentially increasing the risk and severity of alcohol use disorders and withdrawal syndromes in later life (Lockhart, 2001; Smith et al., 2002). Conversely, the aging brain exhibits unique vulnerabilities that can complicate the course of alcohol withdrawal (Missler et al., 1999).

### Prenatal Exposure and Fetal Alcohol Spectrum Disorders (FASD)

Exposure to alcohol during gestation can lead to a range of developmental abnormalities known as Fetal Alcohol Spectrum Disorders (FASD), with Fetal Alcohol Syndrome (FAS) being the most severe presentation (Lockhart, 2001; Hodge, 1989). FAS is characterized by a distinct pattern of facial dysmorphia, growth retardation, and significant CNS damage (Lewis & Woods, 1994; Coles, 2003). The neurological consequences are pervasive and can include mental retardation, developmental delays, and a host of cognitive and behavioral problems such as attention deficits, impulsivity, poor social skills, and impaired executive functioning (Lockhart, 2001; Coles, 2003). Newborns with FAS may even exhibit a neonatal withdrawal syndrome characterized by irritability, hypotonia, and severe tremors (Lewis & Woods, 1994).

The neurobiological damage caused by prenatal alcohol exposure creates a lifelong vulnerability. The brain alterations seen in FASD, which result from alcohol's interference with critical developmental processes like neuronal migration and synaptogenesis, may predispose these individuals to developing substance use disorders later in life (Alfonso‐Loeches & Guerri, 2011; Lockhart, 2001). The cognitive and behavioral problems characteristic of FASD, such as impulsivity and poor judgment, are themselves risk factors for initiating and maintaining substance use (Smith et al., 2002). Therefore, prenatal alcohol exposure can be seen as an early developmental insult that increases the long-term risk for alcohol dependence and, consequently, for experiencing alcohol withdrawal.

### Adolescence as a Critical Period of Vulnerability

Adolescence is a period of significant brain maturation, particularly in the prefrontal cortex and limbic systems, which are crucial for impulse control, decision-making, and emotional regulation (Smith et al., 2002). Alcohol use during this critical developmental window can disrupt these maturational processes, leading to long-term consequences (Alfonso‐Loeches & Guerri, 2011).

Adolescents who abuse alcohol are more likely to drop out of school, engage in risky behaviors, and develop alcohol dependence (Takahashi & Franklin, 1996; Smith et al., 2002). There is a strong comorbidity between adolescent-onset disorders like attention-deficit/hyperactivity disorder (ADHD) and the later development of alcohol use disorders (Smith et al., 2002; Batta & Farid, 2011). The core symptoms of ADHD—inattention, impulsivity, and hyperactivity—are significant risk factors for early initiation of alcohol use and a more rapid progression to dependence (Strohbeck-Kuehner et al., 2006).

The adolescent brain may be uniquely sensitive to both the rewarding and the neurotoxic effects of alcohol (Alfonso‐Loeches & Guerri, 2011). This heightened sensitivity could facilitate a faster transition from use to dependence. Consequently, individuals who begin heavy drinking in adolescence may be at higher risk for developing more severe withdrawal syndromes later in life, potentially due to alcohol-induced disruptions in neurodevelopmental trajectories that permanently alter brain excitability and stress-response systems.

### Alcohol Withdrawal in the Elderly

The presentation and management of AWS in older adults pose unique challenges due to age-related physiological changes and the high prevalence of comorbid medical conditions (Missler et al., 1999; Arora et al., 2014). Alcoholism in the elderly population is often underestimated and underdiagnosed, as symptoms like falls, memory loss, and self-neglect may be mistakenly attributed to normal aging or other geriatric syndromes (Arora et al., 2014; McCullough, 1991).

When withdrawal does occur in an older patient, it is often more severe and carries a higher risk of complications (Missler et al., 1999). The aging brain has reduced neuroplasticity and reserve capacity, making it more vulnerable to the neurotoxic effects of withdrawal-related hyperexcitability (Missler et al., 1999). Consequently, elderly patients are at special risk of developing serious complications such as prolonged delirium and withdrawal seizures, which can lead to progressive and sometimes irreversible cognitive decay (Missler et al., 1999; Arora et al., 2014).

Pharmacokinetic changes in the elderly, such as reduced hepatic metabolism and renal clearance, also complicate management. Older adults are more sensitive to the sedative effects of benzodiazepines, the standard treatment for AWS, increasing the risk of over-sedation, falls, and respiratory depression (Riddle et al., 2010; Kumagai & Iseki, 2012). Furthermore, the clinical picture of withdrawal can be obscured by coexisting medical conditions or dementia, making diagnosis difficult (Arora et al., 2014; McCullough, 1991). For instance, the agitation and confusion of delirium tremens can be hard to distinguish from the behavioral and psychological symptoms of dementia (BPSD) or other forms of delirium common in hospitalized older adults (Francis, 1997; Harding, 2005). Therefore, a high index of suspicion is required, and management must be carefully tailored to account for the unique vulnerabilities of the geriatric population (Missler et al., 1999; Evers & Marin, 2002).

In summary, a developmental perspective is essential for a complete understanding of the neurobiology of alcohol withdrawal. Early life exposure to alcohol can establish a lasting vulnerability. Adolescence represents a critical window where alcohol use can disrupt brain development and set a trajectory toward dependence. Finally, old age brings unique physiological changes that increase the risk for severe, complicated withdrawal, demanding specific diagnostic and therapeutic considerations.

## Treatment Mechanisms

The management of alcohol withdrawal syndrome is aimed at ameliorating symptoms, preventing severe complications like seizures and delirium tremens, and facilitating the transition to long-term abstinence (Muncie et al., 2013; Saitz, 1998). The biological basis of AWS, centered on CNS hyperexcitability due to a GABA/glutamate imbalance, provides a clear rationale for the primary pharmacological interventions used (Yersin, 1999; Hemmingsen et al., 1983). This section reviews the mechanisms of action for the key treatments for AWS.

### Benzodiazepines: The Gold Standard of Care

Benzodiazepines are universally recognized as the first-line therapy and gold standard for the management of moderate to severe alcohol withdrawal (Thompson & Weber, 2021; Erstad & Cotugno, 1995; Saitz, 1998; Muncie et al., 2013). Their efficacy stems from their direct action on the GABA-A receptor, the same receptor complex targeted by alcohol (Riddle et al., 2010).

**Mechanism of Action:** Benzodiazepines are positive allosteric modulators of the GABA-A receptor. They bind to a specific site on the receptor complex, distinct from the GABA binding site, and increase the frequency of chloride channel opening in response to GABA (Riddle et al., 2010). This enhances the inhibitory effect of GABA, effectively substituting for the action of alcohol and counteracting the state of neuronal hyperexcitability that drives withdrawal symptoms (Yarlagadda et al., 2007; Zutshi et al., 2007). By restoring inhibitory tone in the CNS, benzodiazepines reduce symptoms of anxiety, agitation, and tremor, and critically, they effectively prevent the progression to generalized seizures and delirium tremens (Erstad & Cotugno, 1995; Thompson & Weber, 2021). Lorazepam, in particular, is noted for its effectiveness in both catatonia and alcohol withdrawal due to its action as a GABA-A modulator (Yarlagadda et al., 2007; Zutshi et al., 2007).

Different benzodiazepines, such as long-acting agents like diazepam and chlordiazepoxide or intermediate-acting agents like lorazepam, appear similarly effective in reducing withdrawal symptoms (Riddle et al., 2010). Long-acting agents may offer a smoother withdrawal course with fewer rebound symptoms and may be more effective in preventing seizures, while shorter-acting agents are often preferred in elderly patients or those with significant liver disease to reduce the risk of over-sedation (Riddle et al., 2010; Erstad & Cotugno, 1995). Treatment can be administered on a fixed-dose schedule or, more efficiently, via a symptom-triggered approach, where medication is given in response to the severity of withdrawal symptoms as measured by a standardized scale like the Clinical Institute Withdrawal Assessment for Alcohol, Revised (CIWA-Ar) (Riddle et al., 2010; Muncie et al., 2013). Symptom-triggered therapy has been shown to require less total medication and a shorter treatment duration (Riddle et al., 2010).

### Anticonvulsants as an Alternative or Adjunct

While benzodiazepines are first-line, other medications, particularly anticonvulsants, have been explored for the treatment of mild to moderate withdrawal, offering an alternative with less abuse potential (Muncie et al., 2013).

**Mechanism of Action:** Anticonvulsants like carbamazepine and gabapentin act through different mechanisms to reduce neuronal excitability. Carbamazepine primarily works by blocking voltage-gated sodium channels, which stabilizes neuronal membranes and reduces their propensity for high-frequency firing (Erstad & Cotugno, 1995). Gabapentin, a structural analog of GABA, is thought to work by binding to the alpha-2-delta subunit of voltage-gated calcium channels, which reduces the release of excitatory neurotransmitters like glutamate (Baldwin & Ajel, 2007). By dampening neuronal excitability through these non-GABAergic mechanisms, these agents can alleviate some of the core symptoms of withdrawal (Muncie et al., 2013). However, evidence that they are as effective as benzodiazepines in preventing severe complications like seizures and delirium is insufficient, and they are often considered second-line or adjunctive therapies (Erstad & Cotugno, 1995; Brewer, 1995).

### Adrenergic-Modulating Agents

To target the autonomic hyperactivity characteristic of AWS, medications that modulate the adrenergic system, such as beta-blockers (e.g., propranolol) and alpha-2 agonists (e.g., clonidine), are sometimes used as adjunctive therapy (Brewer, 1995).

**Mechanism of Action:** Beta-blockers act peripherally and centrally to block the effects of catecholamines at beta-adrenergic receptors, thereby reducing heart rate, blood pressure, and tremor (Hart & Anderson, 1981). Clonidine acts centrally on presynaptic alpha-2 autoreceptors to reduce sympathetic outflow from the locus coeruleus, also leading to a decrease in heart rate and blood pressure (Erstad & Cotugno, 1995). While these agents can be effective in controlling the cardiovascular symptoms of withdrawal, they do not address the underlying CNS hyperexcitability and do not prevent seizures or delirium (Brewer, 1995). Therefore, they should only be used as adjuncts to benzodiazepines and never as monotherapy for moderate to severe withdrawal (Brewer, 1995; Hart & Anderson, 1981). Some evidence suggests beta-blockers may even increase the risk of hallucinations (Unknown, 2007).

### Supportive and Metabolic Interventions

Beyond specific neuropharmacological treatments, supportive care is crucial. This includes correcting fluid and electrolyte imbalances that result from diaphoresis, vomiting, and the diuretic effect of alcohol (Erstad & Cotugno, 1995; Riddle et al., 2010).

A critical component of management is thiamine (Vitamin B1) supplementation. Chronic alcoholism leads to poor nutrition and impaired absorption of thiamine, a crucial co-factor for glucose metabolism in the brain (Riddle et al., 2010; Hemmingsen et al., 1983). Thiamine deficiency can lead to Wernicke's encephalopathy, a neurological emergency characterized by confusion, ataxia, and ophthalmoplegia, which can progress to the irreversible memory disorder Korsakoff syndrome (Riddle et al., 2010; Trevisan et al., 1998). Prophylactic administration of thiamine, typically before any glucose-containing fluids, is a standard and essential intervention to prevent this devastating complication (Riddle et al., 2010; Unknown, 2007).

In conclusion, the biological mechanisms of AWS treatments are logically derived from its pathophysiology. Benzodiazepines directly counter the GABAergic deficit, acting as a substitute for alcohol's inhibitory effects. Anticonvulsants offer an alternative route to dampen neuronal hyperexcitability. Adrenergic agents manage the downstream consequences of sympathetic overactivity. Finally, metabolic support, especially with thiamine, prevents severe neurological complications related to nutritional deficiencies common in this population.

## Future Directions

While our understanding of the biological basis of alcohol withdrawal has advanced significantly, numerous questions remain, and the available literature points to several promising avenues for future research. The heterogeneity of the syndrome, its complex interactions with comorbid conditions, and the need for more targeted and personalized treatments highlight critical gaps in current knowledge.

One of the most pressing needs is for more sophisticated neuroimaging studies to delineate the functional and structural consequences of AWS with greater precision. While studies have linked withdrawal severity to grey matter atrophy (Lanièpce et al., 2020), longitudinal research is needed to track these changes over time and determine their reversibility with sustained abstinence. Advanced imaging techniques could clarify the relationship between post-seizure hypoperfusion and long-term cognitive outcomes (Farrell et al., 2016), potentially identifying a window for neuroprotective interventions. Functional connectivity studies could map the dysregulation of brain networks during withdrawal and recovery, providing biomarkers to predict clinical course and treatment response.

The genetic underpinnings of withdrawal severity remain a largely unexplored frontier. While a heritable component is recognized (Kosobud & Crabbe, 1995; DiMartini, 2007), large-scale genomic studies are required to identify specific risk alleles and polygenic risk scores that predict which individuals are most vulnerable to severe complications like seizures and delirium tremens. Identifying these genetic markers could pave the way for personalized medicine, allowing clinicians to stratify patients by risk and tailor the intensity of monitoring and treatment from the outset (Becker, 1998).

Further investigation into the molecular mechanisms of withdrawal, particularly the kindling phenomenon, is crucial. Research should aim to elucidate the specific intracellular signaling cascades and epigenetic modifications that contribute to the long-term synaptic plasticity underlying the progressive worsening of withdrawal episodes (Becker, 1998; Becker & Redmond, 2002). A deeper understanding of these processes could lead to novel therapeutic targets aimed at preventing or reversing kindling-induced hyperexcitability.

The role of neuroinflammation in AWS is another emerging area of interest. Stress and alcohol itself can activate the brain's innate immune system, and the release of inflammatory cytokines may contribute to both the acute symptoms of withdrawal and long-term neurotoxicity (Anisman & Merali, 2003; Alfonso‐Loeches & Guerri, 2011). Future studies should investigate the interplay between stress hormones, cytokines, and neurotransmitter systems during withdrawal and explore the potential of anti-inflammatory agents as adjunctive therapies.

There is also a need to better characterize and understand the biological basis of different clinical subtypes of AWS. For example, the distinction between withdrawal syndromes arising from periodic (binge) versus permanent (continuous) drinking patterns may reflect different underlying neuroadaptations and could have implications for treatment (Kuzminov, 2019). Similarly, the pathophysiology of atypical presentations, such as withdrawal-induced catatonia or psychosis, requires further study to differentiate them from primary psychiatric disorders and guide appropriate management (Yarlagadda et al., 2007; Zutshi et al., 2007; Geoffroy et al., 2012; Barrio et al., 2021).

Finally, the development of novel pharmacotherapies remains a priority. While benzodiazepines are effective, their abuse potential and sedative side effects are significant drawbacks (Erstad & Cotugno, 1995; Unknown, 2015). Research into non-benzodiazepine treatments, such as glutamate modulators, alpha-2-delta ligands (e.g., gabapentin), and other anticonvulsants, should continue, with a focus on large-scale, controlled trials that assess not only symptom reduction but also the prevention of severe complications (Muncie et al., 2013; Brewer, 1995). The ultimate goal is to develop safer, more targeted therapies that can effectively manage withdrawal while minimizing adverse effects and facilitating the transition to long-term recovery.

## Conclusion

Alcohol withdrawal syndrome is a serious neurological condition arising from a state of profound central nervous system hyperexcitability following the cessation of chronic alcohol use. Its biological basis is rooted in a fundamental disruption of neurochemical homeostasis, primarily a severe imbalance between the inhibitory GABAergic and excitatory glutamatergic systems (Yarlagadda et al., 2007; Zutshi et al., 2007; Kašpárek et al., 2014). This imbalance, a direct consequence of the brain's neuroadaptive response to the chronic depressant effects of alcohol, is the engine driving the clinical manifestations of withdrawal, from mild tremors and anxiety to life-threatening seizures and delirium tremens (Saitz, 1998; Thompson & Weber, 2021).

The pathophysiology of AWS is multifaceted, involving a cascade of dysregulation across multiple neurobiological systems. Beyond the core GABA/glutamate disturbance, withdrawal is characterized by a hypofunctional dopaminergic reward system, which contributes to the dysphoria and intense craving that fuel relapse, and a hyperactive noradrenergic system, which generates dangerous autonomic instability (Vendruscolo & Koob, 2019; Benarroch, 2014). These neurochemical storms play out across a distributed network of brain regions, including the limbic system, prefrontal cortex, and brainstem, leading to the complex constellation of emotional, cognitive, motor, and autonomic symptoms that define the syndrome (Page, 1983; Lanièpce et al., 2020).

Evidence suggests that vulnerability to severe withdrawal is influenced by both genetic predispositions and acquired neuroplastic changes (Kosobud & Crabbe, 1995). The phenomenon of kindling, whereby each withdrawal episode sensitizes the brain and increases the severity of subsequent episodes, highlights the progressive and pernicious nature of the underlying pathology, likely mediated by long-lasting changes in synaptic plasticity (Becker, 1998). This progressive neurotoxicity is associated with structural brain damage, including measurable grey matter volume loss, underscoring the physical insult that withdrawal inflicts upon the brain (Lanièpce et al., 2020).

The biological understanding of AWS provides a clear rationale for its management. The efficacy of benzodiazepines, the cornerstone of treatment, lies in their ability to substitute for alcohol at the GABA-A receptor, thereby restoring inhibitory tone and quelling CNS hyperexcitability (Riddle et al., 2010). Adjunctive therapies that target adrenergic hyperactivity or utilize alternative anticonvulsant mechanisms, along with crucial metabolic support like thiamine administration, further demonstrate how a neurobiologically informed approach can mitigate the dangers of withdrawal (Brewer, 1995; Unknown, 2007).

In conclusion, alcohol withdrawal is far more than a transient state of discomfort; it is a manifestation of significant, and potentially progressive, brain dysfunction. A comprehensive understanding of its biological and neurological underpinnings—from receptor plasticity and genetic vulnerability to network-level dysregulation and structural brain changes—is essential for improving diagnosis, preventing severe complications, and developing more effective and targeted therapies to help individuals navigate this dangerous phase of recovery from alcohol dependence.


## References

1. Abdallah, S. J., Poenaru, S., Corrales‐Medina, V., & Cowan, J. (2021). COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review. Therapeutic Advances in Infectious Disease. https://doi.org/10.1177/20499361211009385
2. Abdul‐Khaliq, H., Schubert, S., Stoltenburg-Didinger, G., Hübler, M., Böttcher, W., Triotzsch, D., Hetzer, R., & Lange, P. (2000). Early immunohistochemical brain overexpression of S-100β and increased serum level after deep hypothermic circulatory arrest in rabbits: relationship to perivascular astrocytic swelling. Critical Care. https://doi.org/10.1186/cc674
3. Abhilash, K. P., Jha, A., Bandhyopadhyay, R., & Victor, P. (2014). Hypoglycemia - A rare complication of carbamazepine overdose. Indian Journal of Pharmacology. https://doi.org/10.4103/0253-7613.144941
4. Adams, B., & Bromley, B. (1998). Loss and grief therapy. https://doi.org/10.1007/978-1-349-26634-0_10
5. Ademi, L. A., & Ademi, B. (2017). EVALUATION AND MANAGEMENT OF A CHILD WITH FEBRILE SEIZURE.
6. Agarwal, V., Sitholey, P., & Srivastava, C. (2019). Clinical practice guidelines for the management of dissociative disorders in children and adolescents. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_493_18
7. Ahmed, S., & Paul, S. P. (2019). A Diagnostic Conundrum: Acute Intermittent Porphyria Coexisting with Lumbar Prolapsed Intervertebral Disc. Journal of College of Physicians And Surgeons Pakistan. https://doi.org/10.29271/jcpsp.2019.12.1236
8. Al-Balawi, T., Al-Greeshah, F., & Khan, S. (2003). Management of status epilepticus.. PubMed.
9. Alexandre, S., Misery, L., Dutray, S., Chastaing, M., Consoli, S.-M., Audra, H., Bauer, D., Bertolus, S., Callot, V., Cardinaud, F., Corrin, E., Féton-Danou, N., Malet, R., Touboul, S., & Consoli, S. (2007). Functional Itch Disorder or Psychogenic Pruritus: Suggested Diagnosis Criteria From the French Psychodermatology Group. Acta Dermato Venereologica. https://doi.org/10.2340/00015555-0266
10. Alfarossi, O. L., & Hutasoit, H. B. K. (2020). Gejala Psikotik pada Pasien dengan Epilepsi Tidak Terkontrol. Jurnal Medula.
11. Alfonso‐Loeches, S., & Guerri, C. (2011). Molecular and behavioral aspects of the actions of alcohol on the adult and developing brain. Critical Reviews in Clinical Laboratory Sciences. https://doi.org/10.3109/10408363.2011.580567
12. Ali, A. A., Shaer, S. S. E., Gad, A. M., & Abu‐Elfotuh, K. (2017). [P1–606]: IMPACT OF PHYSICAL AND MENTAL ACTIVITIES VERSUS PROTEIN MALNUTRITION ASSOCIATED WITH SOCIAL ISOLATION DURING INDUCTION AND PROGRESSION OF ALZHEIMER's DISEASE IN RATS. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2017.06.622
13. Alvarez, M. R., García, R. G., & Silva, F. A. (2010). Cefalea por uso excesivo de medicamentos: implicaciones clínicas y terapéuticas. Acta neurológica colombiana.
14. Alvarez, V., & Drislane, F. W. (2016). Is Favorable Outcome Possible After Prolonged Refractory Status Epilepticus?. Journal of Clinical Neurophysiology. https://doi.org/10.1097/wnp.0000000000000223
15. Al‐Mufti, F., & Claassen, J. (2019). Status Epilepticus in the Neurocritical Care Unit. Cambridge University Press eBooks. https://doi.org/10.1017/9781107587908.015
16. Amorim, M. J., Maurício, J., & Brandão, D. (2019). WHEN THE DISEASE ARISES FROM THE TREATMENT: CORTICOSTEROID-INDUCED PSYCHOSIS A CASE REPORT AND BRIEF LITERATURE REVIEW. https://doi.org/10.26226/morressier.5d1a037b57558b317a140b63
17. Ananto, A. S., & Suryati, E. (2019). Ensefalopati Hipertensi pada Anak dengan Glomerulonefritis Akut Pasca Streptokokal.
18. Anderson, J., & Willis, M. (2017). Differentiating Between Postural Tachycardia Syndrome and Vasovagal Syncope. PEDIATRICS. https://doi.org/10.1542/peds.2016-4161
19. Anderson, T., Heitger, M., & Macleod, A. D. (2006). Concussion and mild head injury. Practical Neurology. https://doi.org/10.1136/jnnp.2006.106583
20. Anghelescu, A., Saglam, A.-O., Stoica, S. I., & Onose, G. (2022). Rehabilitation of severe neurological complications post SARS-CoV-2 infection. Balneo and PRM Research Journal. https://doi.org/10.12680/balneo.2022.491
21. Anisman, H., & Merali, Z. (1999). Understanding stress: characteristics and caveats.. PubMed.
22. Anisman, H., & Merali, Z. (2003). Cytokines, stress and depressive illness: brain‐immune interactions. Annals of Medicine. https://doi.org/10.1080/07853890310004075
23. Anisman, H., Merali, Z., Poulter, M. O., & Hayley, S. (2005). Cytokines as a Precipitant of Depressive Illness: Animal and Human Studies. Current Pharmaceutical Design. https://doi.org/10.2174/1381612053381701
24. Arbuck, D. M. (2022). Neurotransmitter-based diagnosis and treatment: A hypothesis (Part 2). Current psychiatry. https://doi.org/10.12788/cp.0253
25. Ariaee, N., & Toussi, A. G. (2014). Psychological Effects of Alcohol Abuse. Asia pacific journal of medical toxicology. https://doi.org/10.22038/apjmt.2014.2898
26. Armstrong, E. (1995). Anxiety and related problems. https://doi.org/10.1007/978-1-349-13362-8_5
27. Arnáez, S. (2019). Vulnerabilidad cognitiva a la hipocondría: intrusiones, valoraciones y creencias disfuncionales/ cognitive vulnerability to hypochondriasis: intrusions, appraisals and dysfunctional beliefs.
28. Arora, A., O'Neill, A., Crome, P., & Martin, F. C. (2014). Clinical Medicine and Substance Misuse. https://doi.org/10.1002/9781118430965.ch5
29. Arpacı, A. H., Koç, A., Gürkan, Ö. E., Tosun, C., & Işık, B. (2017). Emergence Agitation or Excited Delirium. Gazi Medical Journal.
30. Arredondo-Aldana, K., Mera-Posligua, M. J., & Alencastro, J. A. P. (2021). Trastorno Depresivo Persistente y Trastornos de Ansiedad Generalizada Proveniente de un Estrés Post Traumático Crónico: Presentación de un Caso Clínico. Revista Científica Arbitrada en Investigaciones de la Salud GESTAR. https://doi.org/10.46296/gt.v4i8edesp.0027
31. Ashok, K. (2017). Critical Review of Alcohol, Alcoholism and the Withdrawal Symptoms I. Mechanisms of Addiction and Withdrawal Syndrome. Archives of Addiction and Rehabilitation. https://doi.org/10.36959/843/421
32. Autor, S. (2002). CÁPSULAS PARA LA VIDA.- ANSIEDAD. Gaceta UNAM (2000-2009).
33. Av, S. (1995). [Neurological and neurophysiological aspects of the alcohol abstinence syndrome].. PubMed.
34. Awan, K., & Steinberg, M. H. (2017). Medical Conditions That May Cause Cognitive Impairment and Depression. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199959549.003.0005
35. Ayşe, H., Hakkı, ©., Arpacı, A. H., Koç, A., Gürkan, Ö. E., Tosun, C., & Işık, B. (2017). Emergence Agitation or Excited Delirium?. Gazi Medical Journal. https://doi.org/10.12996/gmj.2017.45
36. Backer, W. D. (2006). Obstructive Sleep Apnea-Hypopnea Syndrome. KARGER eBooks. https://doi.org/10.1159/000093150
37. Bahro, M., Missler, G., & Strnad, J. (1999). [Diagnosis and therapy of alcohol-withdrawal symptoms in the elderly: a case report].. PubMed.
38. Bains, N., Abdijadid, S., & Miller, J. (2021). Major Depressive Disorder (Nursing).
39. Baldwin, D. S., & Ajel, K. (2007). Role of pregabalin in the treatment of generalized anxiety disorder. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/nedt.2007.3.2.185
40. Balvir, K. S., Dhanvij, B., Telrandhe, S., & Wajgi, R. D. (2021). A Case Report on Management of Subdural Hematoma. NVEO - NATURAL VOLATILES & ESSENTIAL OILS Journal | NVEO.
41. Banderet, L. E., & Shukitt‐Hale, B. (2002). Cognitive performance, mood, and neurological status at high terrestrial elevation. PsycEXTRA Dataset. https://doi.org/10.1037/e447232006-001
42. Banoczi, W. (2005). How Some Drugs Affect the Electroencephalogram (EEG). American Journal of Electroneurodiagnostic Technology. https://doi.org/10.1080/1086508x.2005.11079518
43. Barolin, G. S. (1998). Rehabilitation hospitalism. International Journal of Rehabilitation Research. https://doi.org/10.1097/00004356-199806000-00008
44. Barreno, E. M., López, M. J. R., & Menéndez, M. J. C. (2003). Trastornos cognitivos y psicóticos en un caso de epilepsia temporal antes y después de la lobectomía.
45. Barrio, P., Seeman, M. V., & González-Rodríguez, A. (2021). Alcohol and Psychosis: A Narrative Review of the Prevalence, Clinical Manifestations, and Management of Alcohol-related Psychotic Symptoms. Current Psychiatry Research and Reviews. https://doi.org/10.2174/2666082217666210602111739
46. Barré, M. (2013). Influence de la cognition sociale (Théorie de l'Esprit) sur la rémission fonctionnelle de la dépression et l'aptitude professionnelle.
47. Barthlen, G., Brown, L. K., & Stacy, C. B. (1998). Polysomnographic documentation of seizures in a patient with obstructive sleep apnea syndrome. Neurology. https://doi.org/10.1212/wnl.50.1.309
48. Barton, S., Karner, C., Salih, F., Baldwin, D. S., & Edwards, S. J. (2014). Clinical effectiveness of interventions for treatment-resistant anxiety in older people: a systematic review. Health Technology Assessment. https://doi.org/10.3310/hta18500
49. Bassetti, C. L., & Karbowski, K. (1990). [Prognostic value of electroencephalography in non-traumatic comas].. PubMed.
50. Batinić, B., Duišin, D., & Vukosavljevic-Gvozden, T. (2017). Neurobiological bases for impulsive and compulsive behaviour: Implications for pharmacological and psychological interventions. Engrami. https://doi.org/10.5937/engrami1701017b
51. Batta, A., & Farid, B. (2011). Addiction in Adolescents ---- A Current Trend.
52. Baumeister, R. F., & Heatherton, T. F. (1996). Self-Regulation Failure: An Overview. Psychological Inquiry. https://doi.org/10.1207/s15327965pli0701_1
53. Becker, H. C. (1998). Kindling in alcohol withdrawal.. PubMed.
54. Becker, H. C., & Redmond, N. (2002). Role of Glutamate in Alcohol Withdrawal Kindling. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-306-4_25
55. Becker, M. A., Weinberger, T. E., & Ocker, L. J. (2022). Mood Disorders. CRC Press eBooks. https://doi.org/10.1201/9781003099062-21
56. Beed, M., Sherman, R. A., & Mahajan, R. (2013). Neurology. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696277.003.0005
57. Belagaje, S., & Bonomo, J. (2012). A Person with Factitious Disorder Presenting with Acute Stroke-Like Symptoms and Receiving Thrombolytic Therapy Twice. Journal of Clinical Case Reports. https://doi.org/10.4172/2165-7920.1000138
58. Benarroch, E. E. (2014). Autonomic Hyperactivity. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199920198.003.0013
59. Benzer, D. G., & Cushman, P. (1980). Alcohol and Benzodiazepines: Withdrawal Syndromes. Alcoholism Clinical and Experimental Research. https://doi.org/10.1111/j.1530-0277.1980.tb04808.x
60. Berg, A. T. (2011). Epilepsy, cognition, and behavior: The clinical picture. Epilepsia. https://doi.org/10.1111/j.1528-1167.2010.02905.x
61. Berg, J., & Grimeland, J. (2012). Obsessive-compulsive disorder in disguise—Case report. Open Journal of Psychiatry. https://doi.org/10.4236/ojpsych.2012.23026
62. Bernardin, F., Maheut-Bosser, A., & Paillé, F. (2014). [Cognitive impairment of alcohol-dependent subjects].. PubMed.
63. Besag, F., Gobbi, G., Aldenkamp, A. P., Caplan, R., Dunn, D. W., & Sillanpää, M. (2016). Psychiatric and Behavioural Disorders in Children with Epilepsy (ILAE Task Force Report): Subtle behavioural and cognitive manifestations of epilepsy. Epileptic Disorders. https://doi.org/10.1684/epd.2016.0816
64. Bilal, A., & Naveed, N. (2022). Biological Rhythms, Disorders and their Energetic : A Review. Journal of Internal Medicine Research & Reports. https://doi.org/10.47363/jimrr/2022(1)104
65. Bingöl, A. (2003). Nadir bir geçici iskemik atak nedeni: nörobrusellozis. https://doi.org/10.1501/0001016
66. Bitnun, A., & Richardson, S. E. (2015). Childhood Encephalitis in Canada in 2015. Canadian Journal of Infectious Diseases and Medical Microbiology. https://doi.org/10.1155/2015/947602
67. Bjorvatn, B., Jernelöv, S., & Pallesen, S. (2021). Insomnia – A Heterogenic Disorder Often Comorbid With Psychological and Somatic Disorders and Diseases: A Narrative Review With Focus on Diagnostic and Treatment Challenges. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2021.639198
68. Blackburn, L. B., Zelko, F., & Shurtleff, H. A. (2001). Seizure disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511545894.008
69. Blanco, C., & Bernardi, S. (2014). Gambling Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg62
70. Blumenthal, J. A., & Lett, H. S. (2005). Depression and Cardiac Risk. Journal of Cardiopulmonary Rehabilitation. https://doi.org/10.1097/00008483-200503000-00005
71. Boettger, M. K., Grotelüschen, M., Voss, A., & Bär, K. (2006). Reduced baroreflex sensitivity in acute alcohol withdrawal syndrome. Klinische Neurophysiologie. https://doi.org/10.1055/s-2006-939108
72. Bogaczewicz, A., Bogaczewicz, J., Woźniacka, A., & Sobów, T. (2014). EPA-1255 – Behavioral symptoms in patients with systemic lupus erythematosus induced by chloroquine-a report of two cases. European Psychiatry. https://doi.org/10.1016/s0924-9338(14)78492-5
73. Borowski, M. (2013). Addiction as a Disease. European Researcher. https://doi.org/10.13187/er.2013.55.1945
74. Bostwick, J., & Rackley, S. (2012). Recognizing Mimics of Depression: The '8 Ds': This Mnemonic Helps Recall Conditions That May Make Medically Ill Patients Appear Depressed. Current psychiatry.
75. Brashear, A., Sweadner, K. J., Cook, J., Swoboda, K. J., & Ozelius, L. J. (2014). ATP1A3-Related Neurologic Disorders. University of Washington, Seattle eBooks.
76. Brewer, C. (1995). SECOND-LINE AND ‘ALTERNATIVE’ TREATMENTS FOR ALCOHOL WITHDRAWAL: ALPHA-AGONISTS, BETA-BLOCKERS, ANTICONVULSANTS, ACUPUNCTURE AND NEURO-ELECTRIC THERAPY. Alcohol and Alcoholism. https://doi.org/10.1093/oxfordjournals.alcalc.a045799
77. Brigham, C. R. (2003). Clinical Update: Grip Strength: An Uncommon Impairment. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2003.sepoct03
78. Brody, D. L. (2019). How Do You Make the Diagnosis of Concussion?. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190054793.003.0003
79. Bromberger, J. T. (1998). Gender and Depression. https://doi.org/10.1093/oso/9780195113969.003.0003
80. Broniarczyk-Czarniak, M., Sowińska, K., Białas, J., & Talarowska, M. (2019). Ciężka depresja z nasilonymi zaburzeniami funkcji poznawczych czy otępienie.
81. Brook, P. R., & Berrios, G. E. (1985). Delusions and the psychopathology of the elderly with dementia. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1985.tb02610.x
82. Brooks, C. N., Talmage, J. B., & Mueller, K. L. (2012). Subjective, Objective, or Both?. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2012.marapr02
83. Brown, S. L. (2006). Deterioration. Epilepsia. https://doi.org/10.1111/j.1528-1167.2006.00682.x
84. Browne, R. B. (2011). The Belle Browne Pain Scale.
85. Brădeanu, A. V., Pascu, L. S., Ungurianu, S., Tutunaru, D., Rebegea, L., Terpan, M., & Ciubară, A. (2019). The Effect of Behaviour in Patients Who Are Hospitalized and Suffer from Alcohol Withdrawal. BRAIN BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE. https://doi.org/10.70594/brain/v10.s2/5
86. Buckley, P., & Foster, A. (2014). Schizophrenia. https://doi.org/10.1007/978-3-7091-0715-7_4
87. Bukhari, S. N. A. (2022). Consequences of Antipsychotic Medications on Mental Health. Current Drug Safety. https://doi.org/10.2174/1574886317666220216101106
88. Burke, A., Yaari, R., Tariot, P. N., Dougherty, J., Fleisher, A., & Brand, H. (2012). The Shadow People. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.12alz01398
89. Burkhart, P. W. M. K. K. (2014). Drugs Highly Associated with Infusion Reactions Reported using Two Different Data-mining Methodologies. Journal of Blood Disorders & Transfusion. https://doi.org/10.4172/2155-9864.1000195
90. Bénony, H., Bénony-Viodé, C., & Dumas, J. (2012). Le trouble hyperkinétique ou déficit de l'attention/hyperactivité. Le point sur... Psychologie.
91. Bénony, H., Bénony-Viodé, C., & Dumas, J. (2012). Les troubles de l'humeur. Le point sur... Psychologie.
92. Cabrejo-Mendoza, H. J., & Albornoz-Muñoz, D. P. (2023). Trastorno de Acumulación: A propósito de un caso. Revista de Neuro-Psiquiatría. https://doi.org/10.20453/rnp.v86i1.4469
93. Caeiro, L., Ferro, J. M., Melo, T. P. E., Canhão, P., & Figueira, M. L. (2013). Post-Stroke Apathy: An Exploratory Longitudinal Study. Cerebrovascular Diseases. https://doi.org/10.1159/000350202
94. Caeiro, L., Ferro, J. M., Melo, T. P. E., Canhão, P., & Figueira, M. L. (2013). Supplementary Material for: Post-Stroke Apathy: An Exploratory Longitudinal Study. Figshare. https://doi.org/10.6084/m9.figshare.5124829
95. Campos, M. P. D. O., Hassan, B. J., Riechelmann, R. P., & Giglio, A. D. (2011). Cancer-related fatigue: a review. Revista da Associação Médica Brasileira (English Edition). https://doi.org/10.1016/s2255-4823(11)70046-7
96. Canapathy, M., Kurushev, J., Chitra, F., & Dash, M. (2019). Impact of Sensory Deprivation on Health Outcome. Acta Scientific Paediatrics. https://doi.org/10.31080/aspe.2019.02.0165
97. Cao, F., Salem, H., Nagpal, C., & Teixeira, A. L. (2017). Prolonged delirium misdiagnosed as a mood disorder. Dementia & Neuropsychologia. https://doi.org/10.1590/1980-57642016dn11-020014
98. Carrera, M. A. V., Correa, S. M. V., Prado, M. M. C., & Granados, K. P. M. (2019). Manejo de intoxicación por opioides. RECIMUNDO. https://doi.org/10.26820/recimundo/3.(4).diciembre.2019.494-510
99. Casanova, Y. C., Torres, M. N., Ramírez, M. D. L., Ferrer, A. B., Calvo, R. N., & Ramos, I. J. (2021). Plan de cuidados de enfermería para paciente con deterioro de la movilidad.. Revista Sanitaria de Investigación.
100. Cassano, G. B., Toni, C., Petracca, A., Deltito, J., Benkert, O., Curtis, G., Hippius, H., Maier, W., Shera, D., & Klerman, G. L. (1994). Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo. European Neuropsychopharmacology. https://doi.org/10.1016/0924-977x(94)90314-x
101. Castellanos, G., Escobar, A. P., & González, B. G. (2006). Estrés y conducta adictiva. DELETED.
102. Castro, P. D. (2008). Paciente con alteración de conciencia en urgencias Patients with alteration of consciousness in the emergency department.
103. Castro, P. D. (2008). Paciente con alteración de conciencia en urgencias. Anales del Sistema Sanitario de Navarra. https://doi.org/10.4321/s1137-66272008000200008
104. Cha, Y., Baloh, R. W., Cho, C., Magnusson, M., Song, J., Strupp, M., Wuyts, F. L., & Staab, J. P. (2020). Mal de débarquement syndrome diagnostic criteria: Consensus document of the Classification Committee of the Bárány Society. Journal of Vestibular Research. https://doi.org/10.3233/ves-200714
105. Chang, Y., Han, I.-W., Na, H. R., & Kim, S.-Y. (2010). Encephalitis Lethargica With Catatonia. Journal of the Korean Neurological Association.
106. Chatterjee, S., Rudra, A., Kirtania, J., Sengupta, S., Moitra, G., Sirohia, S., Wankhade, R., & Banerjee, S. (2006). Postoperative delirium. Indian Journal of Critical Care Medicine. https://doi.org/10.4103/0972-5229.29842
107. Chung, S., Oh, K., Cho, K., & Hwang, I.-K. (2003). Antidepressant-Induced Somnambulism：A Case of Mirtazapine. Sleep Medicine and Psychophysiology.
108. Cianchetti, C., Pruna, D., & Ledda, M. (2013). Epileptic seizures and headache/migraine: A review of types of association and terminology. Seizure. https://doi.org/10.1016/j.seizure.2013.05.017
109. Cisneros, V., & Wray, A. (2017). Febrile Seizure. Journal of Education and Teaching in Emergency Medicine. https://doi.org/10.5070/m521033761
110. Cleeland, C. S., & Mendoza, T. R. (2010). Symptom measurement by patient report. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511780868.028
111. Coccolini, F., Improta, M., Picetti, E., Vergano, L. B., Catena, F., Angelis, N. D., Bertolucci, A., Kirkpatrick, A. W., Sartelli, M., Fugazzola, P., Tartaglia, D., & Chiarugi, M. (2020). Timing of surgical intervention for compartment syndrome in different body region: systematic review of the literature. World Journal of Emergency Surgery. https://doi.org/10.1186/s13017-020-00339-8
112. Cohen, J. A., Mowchun, J. J., Lawson, V. H., & Robbins, N. M. (2016). A 19-Year-Old Male with Stiffness and Weakness After Waking. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190491901.003.0026
113. Coles, C. D. (2003). Individuals Affected by Fetal Alcohol Spectrum Disorder (FASD) and Their Families: Prevention, Intervention and Support.
114. Connell, J., Oldham, M., Pandharipande, P. P., Dittus, R. S., Wilson, A. M., Mart, M. F., Heckers, S., Ely, E. W., & Wilson, J. E. (2022). Malignant Catatonia: A Review for the Intensivist. Journal of Intensive Care Medicine. https://doi.org/10.1177/08850666221114303
115. Cornejo, W., Ortiz, B. R., & Blazicevich, L. (2012). Epidemiology of Tics. InTech eBooks. https://doi.org/10.5772/32426
116. Coronado, L. M. Q., Florez, D. A. C., & Tarazona, M. C. L. (2017). Prevalencia depresión en estudiantes universitarios Bucaramanga 2017.
117. Corretge, M., Ramsay, S. G., & Aditya, H. (2012). P8 Visual hallucinations in a patient treated with ACE inhibitors. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2012-303538.25
118. Corruble, E., Warot, D., & Soubrie, C. (2003). Insomnia linked to medications. SLEEP. https://doi.org/10.1007/978-1-4615-0217-3_20
119. Cortés, M. D. C. M. (2013). Análisis evolutivo y valoración neuropsicológica integral de pacientes con deterioro cognitivo leve o enfermedad de Alzheimer..
120. Couto, F. S. D., & Mendonça, A. D. (2010). Sintomas psiquiátricos e comportamentais da demência. Revista Portuguesa de Clínica Geral. https://doi.org/10.32385/rpmgf.v26i1.10713
121. Cox, D. J., Burket, R. C., Mikami, A. Y., Moore, M., & Merkel, R. L. (2007). ADHD and the Adolescent Driver.
122. Crino, P. B. (2002). Seizures in Acute Neurological Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-094-0_3
123. Cruz, M. C. D., Camargo, R. P. D., Cruz, L. C. D., Schiefelbein, N., Cruz, D. M. D., & Cruz, M. C. C. D. (2020). Migrânea: revisão de literatura. ARCHIVES OF HEALTH INVESTIGATION. https://doi.org/10.21270/archi.v10i2.4670
124. Cruz, S. L., & López, C. B. (2003). Fármacos que producen dependencia física y adicción. Avance y perspectiva.
125. Cummings, P. M., Trelka, D. P., & Springer, K. M. (2013). Poisoning. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511920905.007
126. Czajkowska‐Malinowska, M., & Cofta, S. (2014). Obturacyjny bezdech senny i jego społeczne następstwa.
127. Daley, D. C., & Douaihy, A. (2006). Medications in Dual Recovery. https://doi.org/10.1093/oso/9780195311297.003.0006
128. Daley, D. C., & Douaihy, A. (2006). The Recovery Process for Addiction and Mood Disorders. https://doi.org/10.1093/oso/9780195311297.003.0004
129. Daley, D. C., & Douaihy, A. (2019). Managing Cravings and Urges to Use Substances. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926717.003.0009
130. Daley, D. C., & Douaihy, A. (2019). Substance-Related Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926632.003.0002
131. Dashinie, S., & Renganathan, S. (2014). Major Depressive Disorder without Psychotic Features- A Case Report.
132. Davies, D. (2023). Defining Alcoholism. Routledge eBooks. https://doi.org/10.4324/9781032616988-5
133. Delanerolle, G., Shetty, S., Raymont, V., Hapangama, D. K., Haque, N., Shi, J. Q., Ayis, S., Shetty, A., & Phiri, P. (2021). None. LOJ Medical Sciences. https://doi.org/10.32474/lojms.5.5
134. Dennis, M., Warlow, C. P., Gijn, J. V., Wardlaw, J. M., Bamford, J., Hankey, G. J., Sandercock, P., Rinkel, G. J., Langhorne, P., Sudlow, C., & Rothwell, P. M. (2008). What are This Patient's Problems?: A Problem‐Based Approach to the General Management of Stroke. Stroke. https://doi.org/10.1002/9780470696361.ch11
135. Dhanvij, M. A. S., Shingode, D., & Pathade, A. (2021). Case Report on Acute Transient Psychotic Disorder. Drugs and Cell Therapies in Hematology.
136. Diarra, E., Jedynak, C. P., & Verny, M. (2008). [Tremor in the elderly].. PubMed. https://doi.org/10.1684/pnv.2008.0139
137. Dias, R. D. S. (2010). Estudo comparativo do fenótipo clínico de mulheres com transtorno afetivo bipolar em fase reprodutiva da vida com e sem piora pré-menstrual do humor. https://doi.org/10.11606/t.5.2010.tde-28052010-101220
138. Dilsaver, S. C., Halle, M. H., & Medico, V. J. D. (1991). Symptoms of major depression: acute effect of withdrawing antidepressants. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1991.tb05531.x
139. DiMartini, A. (2007). Natural history of alcohol use disorders in liver transplant patients. Liver Transplantation. https://doi.org/10.1002/lt.21342
140. DM, F. P. G. M., BSc, M. P. C. B., Boyd, D. M., & BSc, M. D. S. S. (2014). Major Medical Problems. https://doi.org/10.1002/9781118690345.ch8
141. Dodick, D. W., & Roarke, M. C. (2007). Familial Hemiplegic Migraine: Permanent Attack‐Related Neurologic Deficits. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2007.00889.x
142. Douma, T. N., Millan, M. J., Olivier, B., & Groenink, L. (2011). Linking Stress and Schizophrenia: A Focus on Prepulse Inhibition. InTech eBooks. https://doi.org/10.5772/26944
143. Dudek, D., & Sobański, J. A. (2012). Mental disorders in somatic diseases: psychopathology and treatment. Polskie Archiwum Medycyny Wewnętrznej. https://doi.org/10.20452/pamw.1539
144. Duletic, N., Mijatovic-Papic, T., Cizmovic, B., & Kusturica, S. (2015). Differential Diagnostic Consideration of the Syndrome of Psychomotor Agitation in Geriatric Population. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)31130-5
145. Duncan, J. S. (1988). Neuropsychiatric aspects of sedative drug withdrawal. Human Psychopharmacology Clinical and Experimental. https://doi.org/10.1002/hup.470030304
146. Dunnigan, M., Czapla, K., Henderson, J. B., & Pelosi, A. J. (1999). The Fluid Retention Syndrome: Recognition, Risk Factors and Management. The Journal of the British Menopause Society. https://doi.org/10.1177/136218079900500206
147. Duval, F., Jautz-Duval, M. M., González, F., & Rabia, H. (2010). Bases neurobiológicas de vulnerabilidad psiquiátrica a lo largo de las etapas de la vida hormonal de la mujer. Revista chilena de neuro-psiquiatría. https://doi.org/10.4067/s0717-92272010000500005
148. Dziegielewski, S. F. (2014). Quick References. https://doi.org/10.1002/9781394260577.bapp01
149. Ebenezer, I. S. (2015). Affective Disorders 2: Bipolar Disorder. https://doi.org/10.1002/9781118385777.ch7
150. Echeverria, M. G. (1881). Alcoholic Epilepsy. Journal of Mental Science. https://doi.org/10.1192/bjp.26.116.489
151. Echeverría, M. G. (1881). Alcoholic Epilepsy. Journal of Mental Science. https://doi.org/10.1192/s0368315x00001614
152. Economou, N. T., Bonakis, A., Ghika, A., Ferini‐Strambi, L., Vassilopoulos, D., & Kyrozis, A. (2011). Lamotrigine Withdrawal may Worsen RBD Symptoms. The Neurologist. https://doi.org/10.1097/nrl.0b013e31822c3e5d
153. Efeoğlu, P., Dağlıoğlu, N., Hilal, A., & Gülmen, M. K. (2013). Drugs Used in Sexual Assaults: Features and Toxicological Investigations. DergiPark (Istanbul University).
154. Elikowski, W., Małek‐Elikowska, M., Fertała, N., & Zawodna-Marszałek, M. (2021). Amiodarone-induced musical hallucinations.. PubMed.
155. Elyasi, F. (2016). Catatonia: extinct, lost, or forgotten?. Journal of Emergency Practice and Trauma. https://doi.org/10.15171/jept.2016.02
156. Erstad, B. L., & Cotugno, C. L. (1995). Management of alcohol withdrawal. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/52.7.697
157. Escobar, M. G. T. (2021). Salud mental y porte de armas en personas que laboran para el Estado como agentes de seguridad. Sapientia. https://doi.org/10.54138/27107566.31
158. Eskander, F. S. L., Hakim, K. Y. K., Ibrahim, D., & ElMallah, W. (2021). Incidence Of Post-Operative Delirium In Geriatric Patients Undergoing Hip Replacement Surgery Using Pre-Operative Haloperidol. QJM. https://doi.org/10.1093/qjmed/hcab086.109
159. Espay, A. J., Fasano, A., Nuenen, B. F. V., Payne, M., Snijders, A. H., & Bloem, B. R. (2012). “On” state freezing of gait in Parkinson disease. Neurology. https://doi.org/10.1212/wnl.0b013e3182477ec0
160. Espiard, M.-L., Lecardeur, L., Abadie, P., Halbecq, I., & Dollfus, S. (2006). Trastorno perceptivo persistente por alucinógenos después del consumo de psilocibina: un estudio clínico. European psychiatry (Ed Española). https://doi.org/10.1017/s1134066500003738
161. Evans, R. W., & Schürks, M. (2008). Alcohol and Cluster Headaches. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2008.01073.x
162. Evers, M. M., & Marin, D. B. (2002). Mood disorders. Effective management of major depressive disorder in the geriatric patient.. PubMed.
163. Fachrudin, D. (2019). Episode Depresif Berat dengan Gejala Psikotik (Studi Kasus dalam Perspektif Psikologi dengan Pendekatan Teori Kognitif Beck). Tunas Medika Jurnal Kedokteran & Kesehatan.
164. Factor, S. A., Podskalny, G. D., & Molho, E. (1995). Psychogenic movement disorders: frequency, clinical profile, and characteristics.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.59.4.406
165. Fahn, S., Greene, P., Ford, B., & Bressman, S. (2003). Movement Disorders. https://doi.org/10.1007/978-1-4757-4552-8_9
166. Fair, N., & Akwe, J. (2015). Alcohol Withdrawal: Prevalence, Trends, and Management.
167. Farooq, H., Mohammad, T., Farooq, A., & Mohammad, Q. (2019). Alcohol Withdrawal Mimicking Neuroleptic Malignant Syndrome. Cureus. https://doi.org/10.7759/cureus.4697
168. Farrell, J. S., Gaxiola‐Valdez, I., Wolff, M. D., David, L. S., Dika, H., Geeraert, B., Wang, X. R., Singh, S., Spanswick, S. C., Dunn, J. F., Antle, M. C., Federico, P., & Teskey, G. C. (2016). Author response: Postictal behavioural impairments are due to a severe prolonged hypoperfusion/hypoxia event that is COX-2 dependent. https://doi.org/10.7554/elife.19352.021
169. Fava, G. A., & Cosci, F. (2019). Understanding and Managing Withdrawal Syndromes After Discontinuation of Antidepressant Drugs. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.19com12794
170. Fazel, M., Reed, R. V., & Goldring, L. (2012). Post-traumatic stress disorder. BMJ. https://doi.org/10.1136/bmj.e3790
171. Ferini‐Strambi, L., Sforza, M., Poletti, M., Giarrusso, F., & Galbiati, A. (2017). Daytime sleepiness: more than just Obstructive Sleep Apnea (OSA). La Medicina del lavoro. https://doi.org/10.23749/mdl.v108i4.6497
172. Ferlazzo, E. (2010). Confusional status epilepticus in elderly. BMC Geriatrics. https://doi.org/10.1186/1471-2318-10-s1-l35
173. Figueiredo, M. D. L. F. (2017). Depressive symptoms in elderly women: knowing them to care for. Rev Rene. https://doi.org/10.15253/2175-6783.2017000200001
174. Filippis, S. D., Salvatori, E., Coloprisco, G., & Martelletti, P. (2006). [Chronic daily headache: management and rehabilitation].. PubMed.
175. Fisher, A. D., Bandini, E., Casale, H., & Maggi, M. (2011). Paraphilic Disorders: Diagnosis and Treatment. https://doi.org/10.1002/9781119963820.ch8
176. Fisher, R. S., Acevedo, C. A., Arzimanoglou, A., Bogacz, A., Cross, J. H., Elger, C. E., Engel, J., Forsgren, L., French, J. A., Glynn, M., Hesdorffer, D. C., Lee, B. I., Mathern, G. W., Moshé, S. L., Perucca, E., Scheffer, I. E., Tomson, T., Watanabe, M., & Wiebe, S. (2014). ILAE Official Report: A practical clinical definition of epilepsy. Epilepsia. https://doi.org/10.1111/epi.12550
177. Flaer, P. J., & AlRubaie, M. (2017). Cannabidiol (CBD): An Innovative Pharmacological Treatment For Obsessive-Compulsive Disorder (OCD).
178. Forbes, F. (2010). Improving recognition and management of ADHD.. Practitioner.
179. Forcén, F. E. (2015). Akathisia: Is Restlessness a Primary Condition or an Adverse Drug Effect? Keep a Discerning Eye out for This Adverse Effect of Antipsychotics and Other Drugs. Current psychiatry.
180. Foreman, J. H. (2012). The effects of prolonged endurance exercise on the neurological system in horses. Comparative Exercise Physiology. https://doi.org/10.3920/cep11019
181. Foroutan, H. R., Vadiee, I., Nabavizadeh, A., Rafiee, M., Imanieh, M. H., Asadipouya, A., & Pirastehfar, M. (2005). CIDP and Achalasia: Two manifestations of a Disease or Coincidental Association. Iranian journal of medical sciences.
182. Forrest, J., Willis, L., Holm, K., Kwon, M. S., Anderson, M. A., & Foreman, M. D. (2007). Recognizing quiet delirium.. PubMed. https://doi.org/10.1097/01.naj.0000265267.77070.0c
183. Francis, J. (1997). Delirium. Geriatric medicine. https://doi.org/10.1007/978-1-4757-2705-0_60
184. Francis, M. V. (2016). Migraine without Aura -Towards a New Definition. Journal of Headache & Pain Management. https://doi.org/10.4172/2472-1913.100008
185. Fried, I., Fahoum, F., Frew, A. J., Andelman, F., Andelman‐Gur, M. M., & Salamon, N. (2021). Laser ablation of human guilt. Brain stimulation. https://doi.org/10.1016/j.brs.2021.11.020
186. Fries, W., Netz, J., Bötzel, K., Steinhoff, B., Hartje, W., & Lachenmayr, B. (2005). Leitlinie zur Beurteilung der Fahreignung bei neurologischen Erkrankungen. Aktuelle Neurologie. https://doi.org/10.1055/s-2005-866913
187. Fröhlich, E. D. (1988). ß-Blockers and Mental Performance. Archives of Internal Medicine. https://doi.org/10.1001/archinte.1988.00380040017002
188. Fujita, M., & Tsuruta, R. (2013). Pathophysiology and prevention of delayed neurological sequelae in carbon monoxide poisoning. Journal of the Japanese Society of Intensive Care Medicine. https://doi.org/10.3918/jsicm.20.373
189. Galasko, D. (2019). Pharmacological Approaches To Behavioral Symptoms In Alzheimer’s Disease. CRC Press eBooks. https://doi.org/10.1201/9780429260353-28
190. Galili, S. F. (2019). Følger af det milde hovedtraume. Dansk Tidsskrift for Akutmedicin. https://doi.org/10.7146/akut.v2i1.104546
191. Gameleira, G. H., & Barbosa, M. L. S. (2019). MANIFESTAÇÕES ATÍPICAS DAS CRISES EPILÉPTICAS. Semana de Pesquisa do Centro Universitário Tiradentes - SEMPESq - Alagoas.
192. Garcia, M. O., Garnica, M. M., Marin, S. G., Martínez, C., Martínez, R. G., & Valle, P. B. D. (2017). A child with Pica. A case presentation. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.472
193. García, M. D. S., & Calderón, R. M. (2010). Síntomas no motores en la enfermedad de Parkinson y estimulación cerebral profunda. Revista de Neurología. https://doi.org/10.33588/rn.50s02.2009745
194. García, R. G., Alvarez, M. R., & Arturo, F. (2010). Cefalea por uso excesivo de medicamentos: implicaciones clínicas y terapéuticas Medication over use headache: clinical and therapeutic implications.
195. Garrabé, J., & Cousin, F. (2012). Acute and transient psychotic disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0081
196. Gautam, S., Jain, A., Gautam, M., Vahia, V., & Gautam, A. (2017). Clinical Practice Guidelines for the Management of Generalised Anxiety Disorder (GAD) and Panic Disorder (PD). Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.196975
197. Gauthier, S. (2006). PL-01-03: Long-term treatment of Alzheimer's disease. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2006.05.004
198. Genazzani, A. D., Ricchieri, F., Lanzoni, C., Strucchi, C., & Jasonni, V. M. (2006). Diagnostic and Therapeutic Approach to Hypothalamic Amenorrhea. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1365.009
199. Genovese, J. P. S., Almenar, R. A., & Veintimilla, M. C. A. (2013). A propósito de un caso de patología dual. Trastorno bipolar tipo I. Dependencia a cocaína y alcohol.
200. Geoffroy, P. A., Rolland, B., & Cottencin, O. (2012). Catatonia and Alcohol Withdrawal: A Complex and Underestimated Syndrome. Alcohol and Alcoholism. https://doi.org/10.1093/alcalc/agr170
201. Giacomo, E. D., Moretti, F., Colmegna, F., & Clerici, M. (2023). Obsessive–compulsive disorder as the onset of bipolar disorder in adolescence. Bipolar Disorders. https://doi.org/10.1111/bdi.13373
202. Glasgow, H. B., Burkholder, J. M., Schmechel, D. E., Tester, P. A., & Rublee, P. A. (1995). Insidious effects of a toxic estuarine dinoflagellate on fish survival and human health. Journal of Toxicology and Environmental Health. https://doi.org/10.1080/15287399509532051
203. Gloth, F. M. (1991). Can Vitamin D Deficiency Produce an Unusual Pain Syndrome?. Archives of Internal Medicine. https://doi.org/10.1001/archinte.1991.00400080144029
204. Gn, K., & Vi, R. (1987). [Emotional behavior disorders in rats during the formation of a generator of pathologically enhanced excitation in the basomedial nuclei of the amygdaloid complex].. PubMed.
205. Gnanamuthu, C. P. (1988). Confusional states and seizures. Postgraduate Medicine. https://doi.org/10.1080/00325481.1988.11700372
206. Goldberg, S., & Chapman, J. (2014). Practice question. Nursing Older People. https://doi.org/10.7748/nop.26.10.14.s18
207. Goldman, W. P., Baty, J., Buckles, V., Sahrmann, S. A., & Morris, J. C. (1999). Motor dysfunction in mildly demented AD individuals without extrapyramidal signs. Neurology. https://doi.org/10.1212/wnl.53.5.956
208. Goldstein, T. R. (2010). Bipolar Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0134
209. González, M. F. A. (2019). DETERMINACIÓN DE LOS EFECTOS FISIOLÓGICOS CAUSADOS POR ESTRÉS ACADÉMICO Y LABORAL EN ESTUDIANTES DE QUÍMICA Y QUÍMICO FARMACÉUTICO BIOLÓGO.
210. González, R. M., Quesada, H. S., & Sancho, L. V. (2010). Episodio mixto secundario al uso de fluoxetina en una paciente con un transtorno afectivo bipolar no diagnosticado. Revista Médica de Costa Rica y Centroamérica.
211. Goodenough, G. K., & Lutz, L. J. (1987). Loss of function in the frail elderly. Postgraduate Medicine. https://doi.org/10.1080/00325481.1987.11699974
212. Goodyer, I., Herbert, J., Tamplin, A. K., & Altham, P. M. E. (2000). Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.177.6.499
213. Grannell, L. (2020). Drug interaction resources: mind the gaps. Australian Prescriber. https://doi.org/10.18773/austprescr.2020.005
214. Grealy, J., BSc, H. M., & Grealy, B. H. J. (2005). Glossary. https://doi.org/10.1002/9780470775103.gloss
215. Groisman, A. E., & Seminatore, M. L. (2003). Children and Adolescents Who Have Schizophrenia. Pediatrics in Review. https://doi.org/10.1542/pir.24.10.356
216. Grosso, S., Cioni, M., Pucci, L., Morgese, G., & Balestri, P. (1999). Selective mutism, speech delay, dysmorphisms, and deletion of the short arm of chromosome 18: a distinct entity?. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.67.6.830
217. Gudelius, C., & Mielke, R. (2008). Fahrtuechtigkeit bei der Alzheimer-Erkrankung. SCHRIFTENREIHE FAHREIGNUNG.
218. Gupta, S., Laddha, A., Chaturvedi, P., Chaturvedi, N., Mishra, A., & Raghvendra, R. (2011). Trends and strategy towards therapies for status epilepticus: A decisive review. International Journal of Pharmaceutical Sciences Review and Research.
219. Guskiewicz, K. M., & Goldman, S. B. (2013). A Changing Landscape: Traumatic Brain Injury in Military Combat and Civilian Athletics. The FASEB Journal. https://doi.org/10.1096/fj.13-1101ufm
220. Guszkowska, M. (2013). [Exercise dependence--symptoms and mechanisms].. PubMed.
221. Guthrie, T. R. (2021). Other Health Impairment (OHI) Disabilities Category and an In-Depth Look at the Most Common Neurobiological Condition for Students. Advances in higher education and professional development book series. https://doi.org/10.4018/978-1-7998-7359-4.ch003
222. Gutiérrez, J. G. A., Gutiérrez, A. C., & Ureña, Y. P. (2022). Riesgo de recurrencia de una primera crisis convulsiva según diversas etiologías. Revista Medica Sinergia. https://doi.org/10.31434/rms.v7i12.910
223. Gómez‐Revuelta, M., Blanco, L. S., Ruíz, M. J., Jenaro, G. P. D. S., Rodríguez, R. L., Olivares, O. P., & Morales, N. N. (2017). A Clinical review about differential diagnosis and comorbidities on premenstrual dysphoric disorder. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.577
224. Güleç, H., Babayiğit, M., Kurtay, A., Şahap, M., Ulus, F., Tutal, Z. B., & Horasanlı, E. (2014). Seizure due to multiple drugs intoxication: a case report. Brazilian Journal of Anesthesiology (English Edition). https://doi.org/10.1016/j.bjane.2014.02.013
225. Hadjikoutis, S., & Sawhney, I. M. S. (2003). Occipital seizures presenting with bilateral visual loss.. PubMed.
226. Hainline, B., Gurin, L., & Torres, D. M. (2019). Concussion Two Weeks Later. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0007
227. Hall, A., Farooq, T. B., & Alcaraz, R. (2022). Hypocalcemia-Induced Reversible Psychosis. Cureus. https://doi.org/10.7759/cureus.20874
228. Hamed, S. A. (2017). The auditory and vestibular toxicities induced by antiepileptic drugs. Expert Opinion on Drug Safety. https://doi.org/10.1080/14740338.2017.1372420
229. Hao, Y., Controzzi, M., Cipriani, C., Popović, D. B., Yang, X., Chen, W., Zheng, X., & Carrozza, M. C. (2013). Controlling hand-assistive devices: utilizing electrooculography as a substitute for vision. IEEE Robotics & Automation Magazine. https://doi.org/10.1109/mra.2012.2229949
230. Harding, S. (2005). Continuing Professional Development Managing delirium in older people.
231. Hart, G. R., & Anderson, R. J. (1981). Withdrawal syndromes and the cessation of antihypertensive therapy.. PubMed.
232. Hasan, S., & D’Adamo, M. C. (2015). Episodic Ataxia Type 1.
233. Hassan, M. S., Sidow, N. O., & Mohamed, N. A. (2022). Transient global amnesia: Uncommon diagnosis of exclusion. Clinical Case Reports. https://doi.org/10.1002/ccr3.6533
234. Hawkes, M. A., & Hocker, S. E. (2021). Status Epilepticus. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0057
235. Hayne, C. H., & Louks, J. L. (1991). Dysphoria in Male Alcoholics with a History of Hallucinations. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/00005053-199107000-00005
236. He, W., Shao, L., Wang, H., Huang, H., Zhang, S., Li, C., Zhang, C., & Yi, W. (2022). Bilateral Anterior Capsulotomy for the Treatment of Refractory Somatic Symptom Disorder: A Case Report. Frontiers in Integrative Neuroscience. https://doi.org/10.3389/fnint.2021.721833
237. HEC, M. (2021). The Impact of Preeclampsia on Work-Related Psychosocial Aspects and Need for Recovery. Reproductive Medicine Gynaecology & Obstetrics. https://doi.org/10.24966/rmgo-2574/100080
238. Hector, M., & Burton, J. (1988). What are the Psychiatric Manifestations of Vitamin B<sub>12</sub> Deficiency?. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.1988.tb04397.x
239. Hegel, M. T., Stanley, M. A., & Arean, P. E. (2002). Minor Depression and 'Subthreshold' Anxiety Symptoms in Older Adults: Psychosocial Therapies and Special Considerations. Generations.
240. Heinzer, R., Jordan, A. S., & Malhotra, A. (2006). Sleep Apnea Syndrome. Wiley Encyclopedia of Biomedical Engineering. https://doi.org/10.1002/9780471740360.ebs1097
241. Hemmingsen, R., & Kramp, P. (1988). Delirium tremens and related clilnical states:| Psychopathology, cerebral pathophysiology and psychochemistry: A two‐component hypothesis concerning etiology and pathogenesis. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1988.tb08575.x
242. Hemmingsen, R., Kramp, P., & Rafaelsen, O. J. (1983). Organic cerebral reactions in alcoholism: psychobiological aspects of treatment.. PubMed.
243. Heuser, K., Olsen, K. B., Ulvin, L. B., Gjerstad, L., & Taubøll, E. (2022). Modern Treatment of Status Epilepticus in Adults. Exon Publications eBooks. https://doi.org/10.36255/exon-publications-epilepsy-status-epilepticus
244. Hillman, D. R., Carlucci, M., Charchaflieh, J., Cloward, T. V., Gali, B., Gay, P. C., Lyons, M. M., McNeill, M. M., Singh, M., Yılmaz, M., & Auckley, D. (2023). Society of Anesthesia and Sleep Medicine Position Paper on Patient Sleep During Hospitalization. Anesthesia & Analgesia. https://doi.org/10.1213/ane.0000000000006395
245. Hirose, S. (2003). The Causes of Underdiagnosing Akathisia. Schizophrenia Bulletin. https://doi.org/10.1093/oxfordjournals.schbul.a007027
246. Hirschfeld, R. M. A., Calabrese, J. R., Frye, M. A., Lavori, P. W., Sachs, G., Thase, M. E., & Wagner, K. D. (2007). Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening.. PubMed.
247. Hj, A., Barrucand, D., & Auzépy, P. (1993). [Alcohol withdrawal syndrome and delirium tremens. Their treatment].. PubMed.
248. Hocker, S. E., Wijdicks, E. F. M., & Rabinstein, A. A. (2013). Refractory status epilepticus: new insights in presentation, treatment, and outcome. Neurological Research. https://doi.org/10.1179/1743132812y.0000000128
249. Hodge, F. S. (1989). Disabled American Indians: A Special Population Requiring Special Considerations. American Indian Culture and Research Journal. https://doi.org/10.17953/aicr.13.3-4.j8kl71657h1400w2
250. Hodges, J. R. (2010). Alzheimer’s disease and other dementias. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199204854.003.2442
251. Hou, S., & Rabchevsky, A. G. (2014). Autonomic Consequences of Spinal Cord Injury. Comprehensive physiology. https://doi.org/10.1002/cphy.c130045
252. Hou, S., & Rabchevsky, A. G. (2014). Autonomic Consequences of Spinal Cord Injury. Comprehensive physiology. https://doi.org/10.1002/j.2040-4603.2014.tb00584.x
253. Houssay, R. (2014). Las suprarrenales en la hipoxia o anoxia. Anales de la Facultad de Medicina. https://doi.org/10.15381/anales.v34i4.9544
254. Huang, K., & Tsai, S. (2012). The importance of measuring impulsiveness in patients with addiction problems. Journal of the Chinese Medical Association. https://doi.org/10.1016/j.jcma.2012.10.003
255. Huis, K. (2014). Suvremeno liječenje paničnog poremećaja.
256. Hybels, C. F., Blazer, D. G., & Steffens, D. C. (2006). Partial remission. A common outcome in older adults treated for major depression.. PubMed.
257. Ilbeigi, M. S., Davidson, M., & Yarmush, J. (1998). An Unexpected Arousal Effect of Etomidate in a Patient on High-dose Steroids . Anesthesiology. https://doi.org/10.1097/00000542-199812000-00045
258. Iliev, B., & Pavlovska, I. (2021). Analysis of Clinical Features of Patients with Depressive Disorder. Journal of Health Medicine and Nursing. https://doi.org/10.7176/jhmn/92-01
259. Ingrassia, G. F. (2012). HISTORICAL EVOLUTION OF MEDICAL KNOWLEDGE IN THE FIELD OF VEGETATIVE STATE.
260. Itani, R., Soubra, L., Karout, S., Rahme, D., Karout, L., & Khojah, H. M. J. (2022). Primary Dysmenorrhea: Pathophysiology, Diagnosis, and Treatment Updates. Korean Journal of Family Medicine. https://doi.org/10.4082/kjfm.21.0103
261. Jahan, A. R., & Burgess, D. M. (2021). Substance Use Disorder. StatPearls.
262. Jain, G., Singhal, S., Goyal, L. K., & Mathur, A. K. (2022). Orthostatic hypotension: An overlooked but clinically decisive entity. Journal of The Indian Academy of Geriatrics. https://doi.org/10.4103/jiag.jiag_24_22
263. Jain, S., Goel, S., & Kapila, S. (2015). Clinical Evaluation Of Psychiatric Emergencies.
264. Jargin, S. V. (2019). Some aspects of tobacco smoking in the context of alcohol drinking, hangover and mental health problems. International Journal of Psychiatry Research. https://doi.org/10.33545/26648962.2019.v1.i2a.10
265. Ji, J. (2012). Distinguishing subclinical (subthreshold) depression from the residual symptoms of major depression.. PubMed. https://doi.org/10.3969/j.issn.1002-0829.2012.05.007
266. John, B., Sulaiman, C. T., Ct, S., George, S., & Reddy, V. R. K. (2013). In vitro screening for acetylcholinesterase inhibition of Baliospermum montanum, Humboldtia brunonis Wall. var. raktapushpa and Pittosporum viridulum.
267. Johnson, J. D. (2012). An essay on morbid sensibility of the stomach and bowels : as the proximate cause, or characteristic condition of indigestion, nervous irritability, mental despondency, hypochondriasis, &c. &c. : to which are added, observations on the diseases and regimen of invalids, on their return from hot and unhealthy climates. General Books.
268. Joshi, S., & Kapur, J. (2012). GABAA Receptor Plasticity during Status Epilepticus. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199746545.003.0041
269. Judd, L. L., Schettler, P. J., Brown, E. S., Wolkowitz, O. M., Sternberg, E. M., Bender, B. G., Bulloch, K., Cidlowski, J. A., Kloet, E. R. D., Fardet, L., Joëls, M., Leung, D. Y., McEwen, B. S., Roozendaal, B., Rossum, E. F. C. V., Ahn, J., Brown, D. W., Plitt, A., & Singh, G. (2014). Adverse Consequences of Glucocorticoid Medication: Psychological, Cognitive, and Behavioral Effects. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2014.13091264
270. Kaggwa, M. M., Nkola, R., Najjuka, S. M., Bongomin, F., Ashaba, S., & Mamun, M. A. (2021). Extrapyramidal Side Effects in a Patient with Alcohol Withdrawal Symptoms: A Reflection of Quality of the Mental Health Care System. Risk Management and Healthcare Policy. https://doi.org/10.2147/rmhp.s314451
271. Kales, S. N. (1993). Carbon monoxide intoxication.. PubMed.
272. Katzman, M. A. (2021). The Diagnosis of Major Depressive Disorder is based on the Person's Reported Experiences and a Mental Status Examination. Journal of Aging and Geriatric Medicine.
273. Kazi, S. E., & Anwar, A. (2022). Pseudobulbar Affect Presenting as Aggressive Behavior. Cureus. https://doi.org/10.7759/cureus.21978
274. Kelly, F. D. (2010). Adjustment Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0015
275. Kemp, S. F., & Lockey, R. F. (2010). Pathophysiology and Organ Damage in Anaphylaxis. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-951-2_3
276. Kennedy, J. E., Jaffee, M. S., & Cooper, D. (2013). Posttraumatic Stress Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625154.da08
277. Kenny, R. A., & Grubb, B. P. (2013). Syncope in the elderly. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198566342.003.0061
278. Khan, I., & Khan, M. A. (2021). Sensory and Perceptual Alterations. StatPearls.
279. Kim, G. S., Nunez, T., & Vargas, E. (2021). Omeprazole-induced Visual Hallucinations: A Case Report. Journal of Psychiatric Practice. https://doi.org/10.1097/pra.0000000000000575
280. Kipen, H. M., Fiedler, N., & Lehrer, P. M. (1997). Multiple Chemical Sensitivity. Clinical Pulmonary Medicine. https://doi.org/10.1097/00045413-199703000-00003
281. Kircus, E., & Brillhart, B. (1990). Dealing with Substance Abuse Among People with Disabilities. Rehabilitation Nursing. https://doi.org/10.1002/j.2048-7940.1990.tb01487.x
282. Klein, A., Moskau, S., Klockgether, T., & Linnebank, M. (2006). Transient global amnesia like episode in a dialysis patient with severe hyperhomocysteinaemia. Aktuelle Neurologie. https://doi.org/10.1055/s-2006-953442
283. Klein, S. (2015). Autistic phenomena in neurotic patients 1. Routledge eBooks. https://doi.org/10.4324/9781315743882-10
284. Koller, W. C., Weiner, W. J., Perlik, S., Nausieda, P. A., Goetz, C. G., & Klawans, H. L. (1981). Complications of chronic levodopa therapy. Neurology. https://doi.org/10.1212/wnl.31.4.473
285. Koller, W. C., Weiner, W. J., Perlik, S., Nausieda, P. A., Goetz, C. G., & Klawans, H. L. (1981). Complications of chronic levodopa therapy. Neurology. https://doi.org/10.1212/wnl.31.4_part_2.473
286. Konez, O., Pascual-Castroviejo, I., Rocco, C. D., & Ruggieri, M. (2008). Sturge-Weber Syndrome. https://doi.org/10.1007/978-3-211-69500-5_10
287. Kosobud, A., & Crabbe, J. C. (1995). Genetic Influences on the Development of Physical Dependence and Withdrawal in Animals. https://doi.org/10.1093/oso/9780195088779.003.0010
288. Koster, S., Hensens, A. G., Schuurmans, M. J., & Palen, J. V. D. (2011). Consequences of Delirium After Cardiac Operations. The Annals of Thoracic Surgery. https://doi.org/10.1016/j.athoracsur.2011.07.006
289. Kotade, K. B., Pandit, B. S., Gaware, V. M., Dolas, R. T., Dhamak, K. B., Somwanshi, S. B., Nikam, V. K., & Khadse, A. N. (2011). KNOWING DEPRESSION AND PHARMACOLOGICAL, NON-PHARMACOLOGICAL APPROACHES FOR ITS TREATMENT.
290. Kranaster, L., Aksay, S. S., Bumb, J. M., Janke, C., & Sartorius, A. (2017). The “Forgotten” Treatment of Alcohol Withdrawal Delirium With Electroconvulsive Therapy: Successful Use in a Very Prolonged and Severe Case. Clinical Neuropharmacology. https://doi.org/10.1097/wnf.0000000000000224
291. Krantz, D. S., Gabbay, F. H., Hedges, S. M., Leach, S., Gottdiener, J. S., & Rozanski, A. (1993). Mental and Physical Triggers of Silent Myocardial Ischemia: Ambulatory Studies Using Self-Monitoring Diary Methodology. Annals of Behavioral Medicine. https://doi.org/10.1093/abm/15.1.33
292. Ksiądzyna, D., Merwid‐Ląd, A., Matuszewska, A., Grotthus, B., & Szeląg, A. (2019). Objawy odstawienia wybranych leków. Część I. Medycyna Rodzinna. https://doi.org/10.25121/mr.2019.22.1.27
293. Ksiądzyna, D., Merwid‐Ląd, A., Matuszewska, A., Grotthus, B., & Szeląg, A. (2019). Objawy odstawienia wybranych leków. Część II. Medycyna Rodzinna. https://doi.org/10.25121/mr.2019.22.1.33
294. Kulkarni, S. N., O'Farrell, I., Erasi, M., & Kochar, M. S. (1998). Stress and hypertension.. PubMed.
295. Kumagai, R., & Iseki, E. (2012). [Psychotropic medication of elderly patients].. PubMed.
296. Kumar, S., & Browne, M. O. (2003). What are the effects of drug treatments for panic disorder?. Evidence-Based Mental Health. https://doi.org/10.1136/ebmh.6.2.34
297. Kumar, S., & Flemming, K. D. (2021). Syndromes of Cognitive Dysfunction. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0076
298. Kumari, D., & Kumar, P. (2023). Psychosocial Functioning of Females with Chronic Anxiety Disorder. Journal of Psychosocial Well-being. https://doi.org/10.55242/jpsw.2023.4107
299. Kuzminov, V. (2019). he dependence of the clinical picture of acute psychosis connected with alcohol withdrawal from the forms of alcohol consumption. Ukrains kyi Visnyk Psykhonevrolohii. https://doi.org/10.36927/2079-0325-v27-is1-2019-16
300. Lahey, B. B. (2021). Dimensions of Externalizing Problems. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197607909.003.0004
301. Lammers, M., & Ahmed, A. (2013). Melatonin for Sundown Syndrome and Delirium in Dementia: Is It Effective?. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.12296
302. Langguth, B., Bär, R., Wodarz, N., Wittmann, M., & Laufkötter, R. (2011). Paradoxical Reaction in ADHD. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2011.0541a
303. Lanier, J. B., Mote, M. B., & Clay, E. C. (2011). Evaluation and management of orthostatic hypotension.. PubMed.
304. Lanièpce, A., Cabé, N., André, C., Bertran, F., Boudehent, C., Lahbairi, N., Maillard, A., Mary, A., Segobin, S., Vabret, F., Rauchs, G., & Pitel, A. (2020). The effect of alcohol withdrawal syndrome severity on sleep, brain and cognition. Brain Communications. https://doi.org/10.1093/braincomms/fcaa123
305. Lanzaro, M. (2017). A new syndrome? The sport identification addiction and the case of Italian football ultra-fanatical support. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.508
306. Larrabee, H., & Willard, L. A. (2014). Altered mental status. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139629058.008
307. Lavigne, G., Babiloni, A. H., Beetz, G., Fabbro, C. D., Sutherland, K., Huynh, N., & Cistulli, P. A. (2019). Critical Issues in Dental and Medical Management of Obstructive Sleep Apnea. Journal of Dental Research. https://doi.org/10.1177/0022034519885644
308. Leiblum, S. R. (2003). Arousal disorders in women: complaints and complexities. The Medical Journal of Australia. https://doi.org/10.5694/j.1326-5377.2003.tb05392.x
309. Lenz, G. R., Schoepke, H. G., & Spaulding, T. C. (2000). Anesthetics. Kirk-Othmer Encyclopedia of Chemical Technology. https://doi.org/10.1002/0471238961.0114051912051426.a01
310. Leong, K., Paramlall, M., Swanepoel, H., & Herrod, J. (2022). 35 Processing speed (PS) improvement in alcohol related brain damage (ARBD). Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2022-bnpa.35
311. Lewis, D., & Woods, S. E. (1994). Fetal alcohol syndrome.. PubMed.
312. LEÓN-CARRIÓN, M. D. R. D. M. J. (2006). Low-level responsive states. Taylor & Francis eBooks. https://doi.org/10.4324/9780203965238-15
313. Lečić-Toševski, D. M., Pejović-Milovančević, M., Popović-Deušić, S., & Šušić (2007). [Psychiatric aspects of sleep].. PubMed.
314. Ligier, F., & Kabuth, B. (2016). Between Neurology and Psychiatry, a Difficult Preliminary Diagnosis of Kleine-levin Syndrome: Case-report of a Young Girl. Journal of Child and Adolescent Behaviour. https://doi.org/10.4172/2375-4494.1000274
315. Lim, S., Wadia, P. M., Armstrong, M. J., Schenck, C. H., & Lang, A. E. (2015). Augmented Restless Legs Syndrome with Marked Hyperkinesias and Impulsive‐Compulsive Behaviors. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.12299
316. Lin, B. (2013). Encephalopathy: A Vicious Cascade Following Forebrain Ischemia and Hypoxia. Central Nervous System Agents in Medicinal Chemistry. https://doi.org/10.2174/1871524911313010008
317. Liu, G., Slater, N., & Perkins, A. (2017). Epilepsy: Treatment Options.. PubMed.
318. Llcms, L. C., Martins, P. R. C., Loures, É. N., Vitalino, A. R., Lotufo, C. C., & Onady, S. Y. (2017). ATAQUE ISQUÊMICO TRANSITÓRIO E ESTADO DE MAL EPILÉPTICO COMO MANIFESTAÇÕES DE INTOXICAÇÃO AGUDA E ABSTINÊNCIA POR CRACK E COCAÍNA.
319. Lockhart, P. J. (2001). Fetal alcohol spectrum disorders for mental health professionals - a brief review. Current Opinion in Psychiatry. https://doi.org/10.1097/00001504-200109000-00007
320. Lopes, R., Azevedo, J., Curral, R., Esteves, M., Coelho, R., & Roma‐Torres, A. (2013). OBSTRuCTive Sleep ApneA mAnifeSTed AS An ATypiCAl mAjOR depReSSive diSORdeR: A CASe RepORT And Review Of The liTeRATuRe. Arquivos de Medicina.
321. Lundh, H., & Tunving, K. (1981). An extrapyramidal choreiform syndrome caused by amphetamine addiction. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.44.8.728
322. Luthra, M. (2017). Depression: Current Scenario with reference to India. Indian Journal of Community Health. https://doi.org/10.47203/ijch.2017.v29i01.001
323. Lyketsos, C. G. (2012). F1‐01‐02: Tackling overlap of neuropsychiatric symptoms in Alzheimer's and other dementias: Toward a unified approach to evaluation and treatment. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2012.05.191
324. López, A. M., Martínez, L. R. D., & Moreno, J. (2012). Uso de marcadores bioquímicos para valoración de riesgo de crisis convulsivas en el síndrome de supresión etílica. Salud Mental.
325. M.Sc., D. A. V. S. D. R. (1989). Generalized anxiety disorder.. PubMed.
326. Machado, C. F. A., & Siqueira, E. C. D. (2022). Uma abordagem geral do Transtorno de Estresse Pós-Traumático: revisão de literatura. Revista Eletrônica Acervo Médico. https://doi.org/10.25248/reamed.e10939.2022
327. Madden, J. S. (1993). Alcohol and depression.. PubMed.
328. Madhavan, J. (2017). Ayurvedic Approach to Alcohol Withdrawal Syndrome. International Journal of Complementary & Alternative Medicine. https://doi.org/10.15406/ijcam.2017.07.00226
329. Maeda, M., Nagasawa, H., Yorizumi, K., Sayama, S., & Ogino, H. (1991). Compulsive Manipulation of Tools and Its Clinical Symptomatology.. Shitsugoshō kenkyū/Shitsugoshou kenkyuu. https://doi.org/10.2496/apr.11.187
330. Mahadevan, J., D’cruz, M., Chand, P., & Murthy, P. (2019). An interesting presentation of psychotic catatonia in an elderly patient with alcohol dependence. Journal of Geriatric Mental Health. https://doi.org/10.4103/jgmh.jgmh_33_19
331. Mahato, T. K., Ojha, S. K., Singh, V., & Parihar, S. P. S. (2021). Addiction withdrawal syndrome: Needs medications, education, counselling &amp; support. World Journal of Advanced Research and Reviews. https://doi.org/10.30574/wjarr.2021.12.2.0573
332. Mahon, S. M., & Carr, E. (2021). Fatigue/Lack of Endurance: Common Side Effect. Clinical journal of oncology nursing. https://doi.org/10.1188/21.cjon.s2.25
333. Malka, R. (1988). Role of drug therapies in the treatment of alcoholism: alcohol and anxiety--alcohol and depression.. PubMed.
334. Maneeton, N., & Maneeto, B. (2013). Management of Delirium. InTech eBooks. https://doi.org/10.5772/52756
335. Manica, A., Leães, C. G. S., Frey, B. N., & Juruena, M. F. (1999). The role of depression in coronary artery disease. Arquivos Brasileiros de Cardiologia. https://doi.org/10.1590/s0066-782x1999000800012
336. Manschreck, T. C. (1996). Delusional disorder: the recognition and management of paranoia.. PubMed.
337. Mardani, M. (2017). Can Antibiotic Induce Mental Status Change?. Archives of Clinical Infectious Diseases. https://doi.org/10.5812/archcid.45895
338. Martins, B. A., Madureira, R. S., Freitas, R. C., & Guidoreni, C. G. (2017). Enxaqueca. Congresso Médico Acadêmico UniFOA.. https://doi.org/10.47385/cmedunifoa.451.4.2017
339. Martins, J. R. D. S., Vaz, R., Costa, A., Brás, J., Sousa, R., Abreu, J., Almeida, E., Andrade, R., Castro, N., & Casanova, T. (2023). Postpartum Delirium: A Psychosis Born in the 18th Century. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.2398
340. Mauri, M., & Ramacciotti, D. (2006). Sintomi Psichici e Somatici dei Disturbi dell'Umore: razionali di terapia. Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology.
341. Mavridis, I. N., Meliou, M., & Pyrgelis, E. (2017). Presenting Symptoms of Pituitary Apoplexy. Journal of Neurological Surgery Part A Central European Neurosurgery. https://doi.org/10.1055/s-0037-1599051
342. Maxwell, R. A., & Eckhardt, S. B. (1990). Imipramine. Drug Discovery. https://doi.org/10.1007/978-1-4612-0469-5_10
343. McCullough, P. K. (1991). Geriatric depression: atypical presentations, hidden meanings.. PubMed.
344. McGillion, M., O’Keefe-McCarthy, S., & Carroll, S. (2013). Self-Management Training for Chronic Stable Angina: Theory, Process, and Outcomes. InTech eBooks. https://doi.org/10.5772/54635
345. McIntyre, R. S., & Calabrese, J. R. (2019). Bipolar depression: the clinical characteristics and unmet needs of a complex disorder. Current Medical Research and Opinion. https://doi.org/10.1080/03007995.2019.1636017
346. Medina, S., & Fernando, D. (2019). Caso Christopher : El deseo, de deseo imposible en la neurosis obsesiva..
347. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). [Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly].. PubMed.
348. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). Diagnóstico y tratamiento del insomnio en el adulto mayor.
349. Mehta, U. M., Kumar, C. N., Venkatasubramanian, G., & Thirthalli, J. (2013). Multimodal Sensory Distortions in Postpartum Exacerbation of Schizophrenia. Clinical Schizophrenia & Related Psychoses. https://doi.org/10.3371/csrp.meku.112013
350. Meier, P. J. (1985). Alkohol, Alkoholismus und Arzneimittel.
351. Mellero, D. (2007). Ansiedade em situações de convívio social em idosos.
352. Mensack, S. (2021). Respiratory Alkalosis. Critical care. https://doi.org/10.1201/9781315140629-19
353. Mercês, T. M. D. (2019). Controle hidroeletrolítico e respostas cardiovasculares à injeção central de angII, carbacol e hiperosmolaridade plasmática em ratos com epilepsia induzida por pilocarpina.
354. Meyer, J. S., & Hamel, A. F. (2014). Models of Stress in Nonhuman Primates and Their Relevance for Human Psychopathology and Endocrine Dysfunction. ILAR Journal. https://doi.org/10.1093/ilar/ilu023
355. Michie, S. (2002). CAUSES AND MANAGEMENT OF STRESS AT WORK. Occupational and Environmental Medicine. https://doi.org/10.1136/oem.59.1.67
356. Michiels, J., Berneman, Z., Gadisseur, A., Lam, K. H., Raeve, H. D., & Schroyens, W. (2014). Aspirin-Responsive, Migraine-Like Transient Cerebral and Ocular Ischemic Attacks and Erythromelalgia in JAK2&lt;sup&gt;V617F&lt;/sup&gt;-Positive Essential Thrombocythemia and Polycythemia Vera. Acta Haematologica. https://doi.org/10.1159/000360388
357. Michopoulos, I., Gournellis, R., Papadopoulou, Μ., Plachouras, D., Vlahakos, D. V., Tournikioti, K., Tsigkaropoulou, E., & Lykouras, L. (2012). A Case of Autophagia. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/nmd.0b013e318243989b
358. Mir, J. A., Mushtaq, B., & Mushtaq, O. A. (2022). Clinical case report on bipolar affective disorder, mania. IP Journal of Paediatrics and Nursing Science. https://doi.org/10.18231/j.ijpns.2022.007
359. Miyata, H., Kono, J., & Yanagita, T. (2005). Clinical features of nicotine dependence.
360. Mohite, S., Osman, O. T., Shahani, L., & Teixeira, A. L. (2022). Akathisia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197574317.003.0004
361. Montalto, S. A. (2021). Intrapartum Asphyxia and Its Sequelae. Cambridge University Press eBooks. https://doi.org/10.1017/9781108863049.061
362. Montgomery, S., Bebbington, P., Cowen, P. J., Deakin, J., Freeling, P., Hallström, C., Katona, C., King, D. S., Leonard, B., Levine, S., Phanjoo, A. L., Peet, M., Thompson, C. M., & Thompson, C. M. (1993). Guidelines for treating depressive illness with antidepressants: A statement from the British Association for Psychopharmacology. Journal of Psychopharmacology. https://doi.org/10.1177/0269881193007001041
363. Moore, D. P., & Puri, B. K. (2012). Textbook of Clinical Neuropsychiatry and Behavioral Neuroscience 3E.
364. Morales, D. O. (2019). Muerte encefálica en pediatría..
365. Morell, I. B. (2011). Caracterització farmacològica de moduladors gabaèrgics per al tractament de l’insomni primari. TDX (Tesis Doctorals en Xarxa).
366. Morgan, W. P. (1983). Hyperventilation Syndrome: A Review. AIHAJ. https://doi.org/10.1080/15298668391405562
367. Morimatsu, M. (2021). Prolonged Loss of Consciousness in Parkinson’s Disease. Research Square (Research Square). https://doi.org/10.21203/rs.3.rs-494640/v1
368. Morin, C. M., & Edinger, J. D. (2008). Sleep/Wake Disorders. https://doi.org/10.1093/oso/9780195374216.003.0019
369. Morris, D. M. (1988). Management of perinatal bereavement.. Archives of Disease in Childhood. https://doi.org/10.1136/adc.63.7.870
370. Mospan, C. M. (2021). Chapter 14: Headache. The American Pharmacists Association eBooks. https://doi.org/10.21019/9781582123592.ch14
371. Muncie, H. L., Yasinian, Y., & Oge, L. K. (2013). Outpatient management of alcohol withdrawal syndrome.. PubMed.
372. Munir, S., & Takov, V. (2021). Generalized Anxiety Disorder. StatPearls.
373. Munir, S., Takov, V., & Coletti, V. A. (2021). Generalized Anxiety Disorder (Nursing).
374. Mut, E. A., Pălădoiu, C., & Stănescu, M. (2021). Somatoform and conversion disorders as psychological defences. Journal of Educational Sciences & Psychology. https://doi.org/10.51865/jesp.2021.1.19
375. Méndez, A. V., Silva, P. L. N. D., Gonçalves, L. G. V., Chaves, S. C. D. S., Veiga, R. M., Mendez, A. E. R., Camilo, M. V. L., Mattos, L. C. D. A. N., Filho, M. R. S., Silva, R. D. G. D., Lima, G. F., Ferreira, C. S., & Santos, L. G. D. S. (2023). NEURONAL DAMAGE IN STATE EPILEPTICUS - LITERATURE REVIEW. International Journal of Health Science. https://doi.org/10.22533/at.ed.1593752318094
376. Mırsal, H., Yaluğ, İ., Tan, D., Stern, T. A., Kalyoncu, A., Pektaş, Ö., Erdoğan, G., & Beyazyürek, M. (2005). Brief Report. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.v07n0505
377. Naidoo, S. (2015). Managing stress in the dental environment.
378. Nakata, C., Nara, K., Kinoshita, F., Kikuchi, K., & Asai, M. (2015). [Alcohol withdrawal syndrome showing various progress: A case report].. PubMed.
379. Nakayama, H., Mihara, S., Sakuma, H., Kitamura, D., & Higuchi, S. (2014). SY08-3 * CO-MORBIDITY OF INTERNET ADDICTION. Alcohol and Alcoholism. https://doi.org/10.1093/alcalc/agu052.39
380. Neufeld, K. J., Needham, D. M., Oh, E. S., Wilson, L. M., Nikooie, R., Zhang, A., Koneru, M., Balagani, A., Singu, S., Aldabain, L., & Robinson, K. A. (2019). Antipsychotics for the Prevention and Treatment of Delirium. https://doi.org/10.23970/ahrqepccer219
381. Newman, L. C. (2008). Classification and Diagnosis of Secondary Headaches: Substances, Metabolic Disorders, EENT Causes, and Neuralgias. https://doi.org/10.1093/oso/9780195366730.003.0009
382. Ng, M. H. S., Ming, J., & Beng, N. (2021). Insomnia in the Elderly: Evaluation and Management. The Singapore Family Physician. https://doi.org/10.33591/sfp.47.2.u3
383. Nicolson, G. L., Nasralla, M. Y., Haier, J., & Nicolson, N. L. (1999). GULF WAR ILLNESSES: ROLE OF CHEMICAL, RADIOLOGICAL AND BIOLOGICAL EXPOSURES.
384. Nielsen, J. F., Klemar, B., Hansen, H., & Sinkjær, T. (1995). A new treatment of spasticity with repetitive magnetic stimulation in multiple sclerosis.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.58.2.254-a
385. Nolan, J. P., Soar, J., Gwinnutt, C., Carroll, C., & Sebastian, J. S. (2012). Neurological Emergencies. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199588978.003.0036
386. Nyhan, W. L., Hoffmann, G. F., Al‐Aqeel, A. I., & Barshop, B. A. (2020). Argininemia. CRC Press eBooks. https://doi.org/10.1201/9781315114033-30
387. Oh, S.-H. (2019). 12 - CAN RORSCHACH DIFFERENTIATE BIPOLAR DISORDER FROM DEPRESSIVE DISORDER? : COMPARISON OF RORSCHACH SCORES BETWEEN BIPOAR DEPRESSION AND UNIPOLAR DEPRESSION. https://doi.org/10.26226/morressier.5d1a038757558b317a13f97e
388. Ojimba, C., Isidahome, E. E., Odenigbo, N., Umudi, O. D., & Olayinka, O. (2019). Catatonia in major depressive disorder: diagnostic dilemma. A case report. Journal of Psychology & Clinical Psychiatry. https://doi.org/10.15406/jpcpy.2019.10.00651
389. Ori, Y., & Solun, B. (2011). Severe hiccups associated with intra-articular corticosteroid injection — A case report. Open Medicine. https://doi.org/10.2478/s11536-011-0105-2
390. Otsuka, K., Kato, S., Abe, T., SUGIYAMA, H., Watanabe, Y., Kobayashi, T., & Okajima, Y. (2002). [Classification of long-term clinical course of 'atypical psychosis': a 20-year follow-up study at a medical school hospital].. PubMed.
391. O’Connor, F. G., & Levine, B. D. (2015). Syncope in Athletes of Cardiac Origin. Current Sports Medicine Reports. https://doi.org/10.1097/01.csmr.0000465136.70746.5b
392. Packard, R. C., & Ham, L. P. (1993). Impairment Ratings for Posttraumatic Headache. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.1993.hed3307359.x
393. Packard, R. C., Weaver, R. G., & Ham, L. P. (1993). Cognitive Symptoms In Patients With Posttraumatic Headache. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.1993.hed3307365.x
394. Page, R. D. (1983). Cerebral dysfunction associated with alcohol consumption.. PubMed.
395. Pal, H., Kumar, R., Bhushan, S., & Berry, N. (2005). Psychiatric co-morbidity associated with pheniramine abuse and dependence. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.46079
396. Palijan, T. Ž., Kovačević, D., & Turcinović, M. K. (2007). Psychodynamic Characteristics of Ego in Alcoholic Offenders and Non-Offenders. Alcoholism Clinical and Experimental Research.
397. Panevska, L. (2012). Case of Panic Disorder with Agoraphobia - Continuum Through Cognitive-Behavioural Therapy. Acta Facultatis Medicae Naissensis. https://doi.org/10.2478/v10283-012-0022-6
398. Papadopoulou, M., Welniarz, Q., Roubertie, A., Gras, D., Milh, M., Panagiotakaki, E., & Roze, E. (2023). Effect of Oxygen Administration on Paroxysmal Motor Events in Alternating Hemiplegia of Childhood. Movement Disorders. https://doi.org/10.1002/mds.29561
399. Paredes, D. F. D., Farfán, J. C. P., Orellana, J. M. F., & Legarda, A. A. B. (2019). Trastorno disfórico premenstrual. RECIAMUC. https://doi.org/10.26820/reciamuc/3.(1).enero.2019.199-217
400. Pary, R., Lippmann, S., & Tobias, C. R. (1988). Depression and Alcoholism: Clinical Considerations in Management. Southern Medical Journal. https://doi.org/10.1097/00007611-198812000-00016
401. Parčina, M. (2017). ORGANIZACIJA RADA USTANOVE ZA ZAPOŠLJAVANJE, RAD I PROFESIONALNU REHABILITACIJU OSOBA S INVALIDITETOM.
402. Paw, H., & Shulman, R. (2014). Management of status epilepticus. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781316182673.042
403. Pechnick, R. N., Cunningham, K. A., & Danovitch, I. (2014). Hallucinogen-Related Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg51
404. Peitl, M. V., Prološčić, J., Zelić, S. B., Skarpa-Usmiani, I., & Peitl, V. (2011). Symptoms of agitated depression and/or akathisia.. PubMed.
405. Pelc, I. (1980). [Etiopathogenic elements of alcoholism].. PubMed.
406. Pelc, I. (1997). [Alcoholism: relapse prevention].. PubMed.
407. Petit, J., & Sansone, R. A. (2011). A Case of Interdose Discontinuation Symptoms With Venlafaxine Extended Release. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.11l01140
408. Petruševičienė, D., & Kriščiūnas, A. (2003). [Occupational therapy for patients after stroke].. PubMed.
409. Peña, D. A., Pérez, M. L., & Pinzón, L. F. C. (2014). Línea de investigación psicología clínica y de la salud..
410. Peña, M. A. M. (2013). Síndrome de sobreentrenamiento. IATREIA.
411. Pich, E. M., Heidbreder, C., Mugnaini, M., & Teneggi, V. (2003). Molecular and Behavioral Aspects of Nicotine Dependence and Reward. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-343-9_16
412. Pizov, A. V. (2022). Peculiarities of insomnia in men and women at different age periods. Meditsinskiy sovet = Medical Council. https://doi.org/10.21518/2079-701x-2022-16-21-112-118
413. Pj, M. (1985). [Alcohol, alcoholism and drugs].. PubMed.
414. Plaut, T., & Weiss, J. M. (2021). Electrodiagnostic Evaluation Of Critical Illness Neuropathy. StatPearls.
415. Politis, M., Wu, K., Molloy, S., Bain, P. G., Chaudhuri, К. R., & Piccini, P. (2010). Parkinson's disease symptoms: The patient's perspective. Movement Disorders. https://doi.org/10.1002/mds.23135
416. Pontius, A. A. (1993). NEUROPSYCHIATRIC UPDATE OF THE CRIME "PROFILE" AND "SIGNATURE" IN SINGLE OR SERIAL HOMICIDES: RULE OUT LIMBIC PSYCHOTIC TRIGGER REACTION. Psychological Reports. https://doi.org/10.2466/pr0.1993.73.3.875
417. Pontius, A. A. (1993). Neuropsychiatric Update of the Crime “Profile” and “Signature” in Single or Serial Homicides: Rule out Limbic Psychotic Trigger Reaction<sup>1</sup>. Psychological Reports. https://doi.org/10.1177/00332941930733pt125
418. Postma, A., Nelson, C. M., Dijk, J. V., & Dijk, R. V. (2010). Deaf Children with Severe Multiple Disabilities:. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780195390032.013.0012
419. Powner, D. J., & Boccalandro, C. (2008). Adrenal insufficiency following traumatic brain injury in adults. Current Opinion in Critical Care. https://doi.org/10.1097/mcc.0b013e3282f57528
420. Prasad, K., Prasad, M., Ramaratnam, S., & Marson, A. G. (2015). Status epilepticus. https://doi.org/10.1002/9781119067344.ch9
421. Pujol, R., & Puel, J. (1999). Excitotoxicity, Synaptic Repair, and Functional Recovery in the Mammalian Cochlea: A Review of Recent Findings. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1999.tb08646.x
422. Putra, H. G. S. A. (2015). GANGGUAN AFEKTIF BIPOLAR MANIA DENGAN PSIKOTIK: SEBUAH LAPORAN KASUS. DOAJ (DOAJ: Directory of Open Access Journals).
423. Pérez, J. M. C. (2003). Clínica de la adicción a pasta base de cocaína. Revista chilena de neuro-psiquiatría. https://doi.org/10.4067/s0717-92272003000100007
424. Pérez, Y. M. M., Ortega, D. L. G., & Torres, S. V. L. (2022). AGITACIÓN PSICOMOTRIZ. PUERTO MADERO EDITORIAL eBooks. https://doi.org/10.55204/pmea.3.c10
425. Qamar, A., Kotha, K., & Ioachimescu, O. C. (2011). Obstructive Sleep Apnea. BENTHAM SCIENCE PUBLISHERS eBooks. https://doi.org/10.2174/978160805267711101010021
426. Raininko, R., Gosky, M., & Padiath, Q. S. (1993). LMNB1-Related Autosomal Dominant Leukodystrophy.
427. Rakofsky, J. J., & Dunlop, B. W. (2014). Treating Bipolar Mania in the Outpatient Setting: Enlist the Help of Family, Employ Evidence-Based Pharmacologic and Psychotherapeutic Strategies. Current psychiatry.
428. Ramakrishnan, N., Bansal, A., & Ponnish, A. S. (2022). Practical approach to sleep disordered breathing. Indian Journal of Respiratory Care. https://doi.org/10.5005/jp-journals-11010-02205
429. Ramdhani, R., & Frucht, S. J. (2014). Movement disorders emergencies. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139175845.028
430. Ranganathan, A., & Beitman, B. D. (1998). Panic disorder: a different perspective.. PubMed.
431. Rani, M. K. S., Fathima, S. T., Gayathri, S. L., Pavani, M., & Swathi, Y. (2022). Detection of Autism Spectrum Disorder using Machine Learning. International Journal of Advanced Research in Science Communication and Technology. https://doi.org/10.48175/ijarsct-7600
432. Rani, S., & Saini, D. S. (2015). Organizational Stress in Relation to Job Satisfaction and General Health of Professional Women. International journal of education and management studies.
433. Rayfield, A., Thomas, C., & Borovicka, M. C. (2014). Management of behavioral and psychological symptoms of dementia: The role of mood stabilizers. Mental Health Clinician. https://doi.org/10.9740/mhc.n204493
434. Reddy, M. S. (2014). Irritability as a Criterion in Diagnosis of Child and Adolescent Bipolar Disorder: Thorny Road Ahead. Indian Journal of Psychological Medicine. https://doi.org/10.4103/0253-7176.130954
435. Renemane, L., Vrubļevska, J., & Cera, I. (2022). First Episode Psychosis Following COVID-19 Vaccination: a Case Report.. PubMed.
436. Rengifo, C. A. (2014). Estudio de caso: Trastorno Obsesivo-Compulsivo. Revista de Investigación Universitaria. https://doi.org/10.17162/riu.v3i2.519
437. Reynolds, C. F., Alexopoulos, G. S., & Katz, I. R. (2002). Geriatric Depression: Diagnosis and Treatment. Generations.
438. Reynolds, E., & Wilson, J. V. K. (2014). Neurology and psychiatry in Babylon. Brain. https://doi.org/10.1093/brain/awu192
439. Riddle, E., Bush, J., Tittle, M., & Dilkhush, D. (2010). Alcohol Withdrawal: Development of a Standing Order Set. Critical Care Nurse. https://doi.org/10.4037/ccn2010862
440. Rietveld, S. (1998). Symptom Perception in Asthma: A Multidisciplinary Review. Journal of Asthma. https://doi.org/10.3109/02770909809068201
441. Ritz, L., Pitel, A., Vabret, F., Eustache, F., & Beaunieux, H. (2012). Alcoolodépendance : atteintes neuropsychologiques et diagnostics différentiels. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2012.0227
442. Roberts, H. J. (1988). Neurological, Psychiatric, and Behavioral Reactions to Aspartame in 505 Aspartame Reactors. Birkhäuser Boston eBooks. https://doi.org/10.1007/978-1-4615-9821-3_45
443. Robinson, C. P., & Hocker, S. E. (2019). Status Epilepticus. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190862923.003.0098
444. Rodrigues, F. D. A. A. (2022). WHAT HAPPENS IN THE BRAIN OF A PERSON WITH DISORDER. International Journal of Health Science. https://doi.org/10.22533/at.ed.1592442202087
445. Roessner, V., & Rothenberger, A. (2014). Tic Disorders. https://doi.org/10.1007/978-3-7091-1501-5_27
446. Ronad, S. V., Patail, C. S., Gondbal, S. H., TC, K., Ronad, M., Pankaja, T., Badesgol, R., & Singhal, P. K. J. (2019). Professionals in metro cities suffer from anxiety disorder. Nursing & Care Open Access Journal. https://doi.org/10.15406/ncoaj.2019.06.00198
447. Rose, M. E., & Grant, J. E. (2010). Alcohol-Induced Blackout. Journal of Addiction Medicine. https://doi.org/10.1097/adm.0b013e3181e1299d
448. Rosenbaum, J. F., & Zajecka, J. (1997). Clinical management of antidepressant discontinuation.. PubMed.
449. Rosli, A. (2017). Antidepressant Activity of Spirulina Platensis in Models of Depression. Psychology and Mental Health Care. https://doi.org/10.31579/2637-8892/003
450. Rubiales, Á. S., Duarte, F. J. B., & Valle, M. L. D. (2015). Es necesario precisar el concepto de sedación. Cuadernos de bioética/Cuadernos de bioética.
451. Sabo-Graham, T., & Seay, A. R. (1998). Consultation with the Specialist: Management of Status Epilepticus in Children. Pediatrics in Review. https://doi.org/10.1542/pir.19.9.306
452. Sahakian, B. J., & Morein‐Zamir, S. (2011). Depression and resilience: insights from cognitive, neuroimaging, and psychopharmacological studies. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780199600434.003.0023
453. Saitz, R. (1998). Introduction to alcohol withdrawal.. PubMed.
454. Sanz, G. L., Ruíz, E. C., & Vázquez, L. S. (2015). Síndrome confusional ag udo en pacientes de edad avanzada con fractura de fémur. Ágora de enfermería.
455. Sarris, J., O’Neil, A., Coulson, C., Schweitzer, I., & Berk, M. (2014). Lifestyle medicine for depression. BMC Psychiatry. https://doi.org/10.1186/1471-244x-14-107
456. Saunders, J. B. (2011). The Biology of Alcohol and Alcohol Misuse. https://doi.org/10.1002/9781118785089.ch4
457. Sawarkar, A., Shambharkar, R., Shambharkar, M., Khandar, J., Sakharwade, P., & Kasturkar, P. (2021). Case Report on Acute Transient Psychotic Disorder. Journal of Pharmaceutical Research International. https://doi.org/10.9734/jpri/2021/v33i45b32783
458. Sazonov, S. (2014). EPA-0651 – The complexity of psychopathological symptom as a possible indication of mental disease's etiology. European Psychiatry. https://doi.org/10.1016/s0924-9338(14)78023-x
459. Scarpino, M., Lanzo, G., Chelazzi, C., Maiorelli, A., Bessi, V., Focardi, M., Lolli, F., & Grippo, A. (2022). Multiple Electroencephalogram Recordings for Monitoring the Evolution of Neurological Complications during Baclofen Withdrawal Syndrome. Case Reports in Critical Care. https://doi.org/10.1155/2022/4245667
460. Schenck, C. H. (2003). Assessment and Management of Insomnia. JAMA. https://doi.org/10.1001/jama.289.19.2475
461. Schildkrout, B. (2011). Specific Mental Signs and Symptoms. https://doi.org/10.1002/9781118083598.ch9
462. Schildkrout, B. (2014). Delirium. https://doi.org/10.1002/9781394260447.ch2
463. Schildkrout, B. (2014). Disease #35: Migraine. https://doi.org/10.1002/9781394260447.ch63
464. Schildkrout, B. (2014). Disease #54: Premenstrual Dysphoric Disorder and Premenstrual Syndrome. https://doi.org/10.1002/9781394260447.ch82
465. Schildkrout, B. (2014). Vegetative Symptoms. https://doi.org/10.1002/9781394260447.ch23
466. Schmauß, M., & Pajonk, F. (2015). Agitation und Aggression in der Psychiatrie. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-0041-111184
467. Schutte, M., Mathias, B., & Hopf, G. (1988). [Adverse effects of antihistaminics].. PubMed.
468. Schwager, H., & BSN, L. T. S. (2019). 09 - TREATMENT OF IATROGENIC OPIOID DEPENDANCE USING BUPERNORPHINE IN PATIENTS WITH CHRONIC PAIN A TELE-BEHAVIORAL MEDICINE PROTOCOL. https://doi.org/10.26226/morressier.5d1a038357558b317a140c62
469. Schwartz, B. (1990). Early information processing in schizophrenia.. PubMed.
470. Scotton, W. J., Hill, L. J., Williams, A., & Barnes, N. M. (2019). Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions. International Journal of Tryptophan Research. https://doi.org/10.1177/1178646919873925
471. Seemüller, F., Allwang, C., & Beraldi, A. (2019). Ist Burnout eine Folge des Arbeitslebens?. Nervenheilkunde. https://doi.org/10.1055/a-0876-9848
472. Sekhon, S., Patel, J., & Sapra, A. (2019). Late Onset Depression. StatPearls.
473. Sengupta, R., Roy, S., & Bhattacharya, M. (2019). STUDY OF GENE-ENVIRONMENT CAUSES OF MAJOR DEPRESSIVE DISORDER TO STATISTICALLY DEFINE THE MOST COMMON CAUSE BEHIND IT.. International Journal of Advanced Research. https://doi.org/10.21474/ijar01/8804
474. Serageldin, M., Hikmet, W., & Alani, S. (2019). Insomnia is a Prodromal Symptom for Psychosis. Journal of the Bahrain Medical Society. https://doi.org/10.26715/jbms.31_31012019
475. Shams, J., Rahmani, B., Asefi, F., & Daneshfar, S. (2010). CATATONIA DEVELOPMENT IN A SCHIZOAFFECTIVE PATIENT FOLLOWING ELECTROCONVULSIVE THERAPY: CASE REPORT.
476. Sharp, L. K., & Lipsky, M. S. (2002). Screening for depression across the lifespan: a review of measures for use in primary care settings.. PubMed.
477. SheikhBahaei, S., Farhan, M., & Maguire, G. A. (2022). Improvement of stuttering after administration of methylphenidate - a case report. Personalized Medicine in Psychiatry. https://doi.org/10.1016/j.pmip.2022.100092
478. Shivani, R., Goldsmith, R. J., & Anthenelli, R. M. (2002). Alcoholism and Psychiatric Disorders: Diagnostic Challenges.. Alcohol Research & Health.
479. Silva, H. M. D., & Cardoso, L. V. (2021). RISADA PEGA: A Mnemonic Method in Portuguese for Alarm Criteria in Emergency Headaches. Deleted Journal. https://doi.org/10.48208/headachemed.2021.supplement.29
480. Silva, L. I. F. D., Souza, L. M., Gonzales, M. F., & Jurado, S. R. (2015). SLEEP DISORDERS IN CHILDHOOD. Simpósio Internacional de Neurociências da Grande Dourados.
481. Singer, W., & Benarroch, E. E. (2014). Postural Tachycardia Syndrome. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199920198.003.0007
482. Singh, S. (2015). Mental health in infancy. International Journal of Clinical & Medical Imaging. https://doi.org/10.4172/2376-0249.1000393
483. Singh, S., & Adam, P. (2015). What can be done to slow progression of Alzheimer's disease in the elderly?. Evidence-Based Practice. https://doi.org/10.1097/01.ebp.0000540940.04507.0e
484. Sinha, R., & Singh, S. (2021). Clinical and Electroencephalogram Correlation of Self-Limited Epilepsy with Autonomic Seizures. Indian Pediatrics Case Reports. https://doi.org/10.4103/ipcares.ipcares_287_21
485. Siu-Fong, O. J., Ming-for, T. T., Lo, I. F. M., Chi-Wai, L., Ting-Yat, M., Trochet, D., & Tak-Sum, L. S. (2006). PHOX2B mutations in three Chinese patients with congenital central hypoventilation syndrome. Chinese Medical Journal. https://doi.org/10.1097/00029330-200610020-00014
486. Skelly, M. K., Demler, T. L., & Lee, C. (2019). High-dose Clozapine Withdrawal: A Case Report and Timeline of a Single Potential Withdrawal Seizure.. PubMed.
487. Slobodin, G., & Odeh, M. (2015). Progressive Brain Atrophy due to Chronic Alcohol Abuse.. PubMed.
488. Smith, B. H., Molina, B. S. G., & Pelham, W. E. (2002). The Clinically Meaningful Link Between Alcohol Use and Attention Deficit Hyperactivity Disorder.. Alcohol Research & Health.
489. Smith, M., Burns, D. E., & Robinson, D. (2002). Geriatric Seizures. Journal of the American Geriatrics Society. https://doi.org/10.1046/j.1532-5415.2002.50234.x
490. Snyder, S. H. (2019). CNS Stimulants And Hallucinogens. CRC Press eBooks. https://doi.org/10.1201/9780429260629-8
491. Sobanski, E., Strohbeck-Kuehner, P., Skopp, G., Mattern, R., & Alm, B. (2006). ADHD and driving-ability.
492. Sobanski, E., Strohbeck-Kuehner, P., Skopp, G., Mattern, R., & Alm, B. (2006). ADHS und Fahreignung / ADHD and driving-ability. Zeitschrift fuer Verkehrssicherheit.
493. Sosin, I., Mysko, G., Sergienko, O., Honcharova, O., Babenko, Y., & Minko, O. (2021). Method of relieving alcohol dysphoria in the structure of hypertoxic alcohol abuse state with compulsive craving manifestations. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.1499
494. Sousa, C. D. (2007). Oral Communication 4, Monday Sept. 24th 5.00 pm-6.00 pm; Room: Lecture Hall 1: Attention, emotion and Behavior--Part 2. Alcohol and Alcoholism. https://doi.org/10.1093/alcalc/agm116
495. Soysal, P., & Işık, A. T. (2014). Hypoactive Delirium Caused by Pulmonary Embolus in an Elderly Adult. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.12720
496. Soyuer, F., & Kepenek-Varol, B. (2019). Quality of life and pain. International Journal of Family & Community Medicine. https://doi.org/10.15406/ijfcm.2019.03.00140
497. Spanagel, R. (2003). Behavioral and Molecular Aspects of Alcohol Craving and Relapse. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-343-9_15
498. Spanagel, R., Tran, B. X., Reyes‐Gibby, C. C., DeBeck, K., Ibrahim, F., & Bonevski, B. (2016). Advances in Drug Addiction.
499. Spector, P. E. (2002). Employee Control and Occupational Stress. Current Directions in Psychological Science. https://doi.org/10.1111/1467-8721.00185
500. Spiegel, E. P., & Vanderploeg, R. D. (2010). Postconcussion Syndrome. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0696
501. Spikina, A., Belov, V., Parfyonov, U. A., & Ermishin, Y. V. (2015). [AGE-SPECIFIC METABOLIC THERAPY FOR ALCOHOL DEPENDENCE IN ELDERLY PATIENTS WITH REGARD TO THEIR AKMEOLOGICAL FEATURES].. PubMed.
502. Squire, L. R. (1989). Amnesia. Birkhäuser Boston eBooks. https://doi.org/10.1007/978-1-4899-6768-8_5
503. Stafstrom, C. E. (1995). Neonatal Seizures. Pediatrics in Review. https://doi.org/10.1542/pir.16.7.248
504. Steenkamp, M. M., & Litz, B. T. (2013). Early Interventions with Military Personnel. Oxford University Press eBooks. https://doi.org/10.1093/med:psych/9780199928262.003.0052
505. Stern, J. M., & Engel, J. (2013). Atlas of EEG Patterns.
506. Stewart, S. M. (2013). Depression. The Encyclopedia of Cross‐Cultural Psychology. https://doi.org/10.1002/9781118339893.wbeccp158
507. Stohler, R., Rommelspacher, H., Ladewig, D., & Dammann, G. (1993). [Beta-carbolines (harman/norharman) are increased in heroin dependent patients].. PubMed.
508. Stone, J., Pal, S., Blackburn, D., Reuber, M., Thekkumpurath, P., & Carson, A. (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
509. Strel'chuk (1983). [Various aspects of the clinical picture and differential treatment of patients with alcoholic delirium].. PubMed.
510. Strupp, M., López‐Escámez, J. A., Kim, J., Straumann, D., Jen, J. C., Carey, J. P., Bisdorff, A., & Brandt, T. (2017). Vestibular paroxysmia: Diagnostic criteria. Journal of Vestibular Research. https://doi.org/10.3233/ves-160589
511. Stubbe, D. (2007). Child and adolescent psychiatry : a practical guide. Lippincott Williams & Wilkins eBooks.
512. Stähli, Müller, E., & Krause, K. (2012). Epileptischer Anfall durch Asystolie oder Asystolie durch Anfallsleiden?. Therapeutische Umschau. https://doi.org/10.1024/0040-5930/a000351
513. Sugimoto, A., Futamura, A., & Kawamura, M. (2013). [Epilepsy and cognitive dysfunction].. PubMed.
514. Summers, C. B. (2007). Cognitive-Behavior Group Therapy in Residential Treatment. https://doi.org/10.4324/9780203941157-16
515. Swarte, R. (2010). The Clinical Value of Intensive Monitoring in Term Asphyxiated Newborns.
516. Sweet, G., Kim, S., Martin, S. A., Washington, N. B., & Brahm, N. C. (2017). Psychiatric symptoms and synthetic cannabinoid use: Information for clinicians. Mental Health Clinician. https://doi.org/10.9740/mhc.2017.07.156
517. Szkodny, L. E., Jacobson, N. C., Llera, S. J., & Newman, M. G. (2014). Generalized Anxiety Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg19
518. Tagaya, H., Murayama, N., & Hakamata, Y. (2012). [Definitions and clinical classifications of sleep disorders].. PubMed.
519. Takahashi, A., & Franklin, J. (1996). Alcohol Abuse. Pediatrics in Review. https://doi.org/10.1542/pir.17-2-39
520. Takahashi, A., & Franklin, J. (1996). Alcohol Abuse. Pediatrics in Review. https://doi.org/10.1542/pir.17.2.39
521. Takaishi, Y., Hashimoto, K., & Enokido, H. (1991). A study of idiopathic epilepsy of childhood with occiptal electroencephalographic foci.. Journal of Nippon Medical School. https://doi.org/10.1272/jnms1923.58.686
522. Takács, R., Milan, F., Ungvári, G. S., Faludi, G., & Gazdag, G. (2016). Catatonia in disulfiram intoxication - a case report and a brief overview of the literature.. PubMed.
523. Talambas, S., Amaral, M. J., Vieira, A., Rodrigues, M., & Manzano, M. N. S. (2022). Impacto Laboral da Perturbação Obsessivo-Compulsiva: Caso Clínico. Revista Portuguesa de Saúde Ocupacional. https://doi.org/10.31252/rpso.12.02.2022
524. Tan, B. L. W., & Gudi, A. (2021). A rare case: Mania associated with pazopanib. Proceedings of Singapore Healthcare. https://doi.org/10.1177/20101058211023778
525. Tatsuzawa, Y., Ono, Y., Takahashi, T., Yoshino, A., & Nomura, S. (2011). Case of isolated adrenocorticotropic hormone deficiency mimicking major depressive disorder. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/j.1440-1819.2011.02207.x
526. Taylor, M. E., & Whitney, J. (2021). Impaired Cognition and Falls. Cambridge University Press eBooks. https://doi.org/10.1017/9781108594455.009
527. Terman, M., & Terman, J. S. (2013). Chronotherapeutics. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139175869.026
528. Thomas, P., Hazif‐Thomas, C., & Clément, J. (2008). [Loss of motivation in the elderly].. HAL (Le Centre pour la Communication Scientifique Directe).
529. Thompson, A., & Weber, A. (2021). Alcohol and Drug Withdrawal Syndromes and Their Clinical Management. DeckerMed Family Medicine. https://doi.org/10.2310/fm.13043
530. Thompson, A., & Weber, A. (2021). Alcohol and Drug Withdrawal Syndromes and Their Clinical Management. https://doi.org/10.2310/cannabis.13043
531. Thompson, A., & Weber, A. (2021). Alcohol and Drug Withdrawal Syndromes and Their Clinical Management. https://doi.org/10.2310/psych.13043
532. Tiglao, S. M., Meisenheimer, E. S., & Oh, R. (2021). Alcohol Withdrawal Syndrome: Outpatient Management.. American family physician.
533. Tito, E., Knapp, B., Bucca, A., & Espiridion, E. D. (2019). A Case Report of Schizoaffective Disorder with Pseudoseizures in a 42-year-old Male. Cureus. https://doi.org/10.7759/cureus.4835
534. Tollefson, G. D., Souêtre, E., Thomander, L., & Potvin, J. H. (1993). Comorbid anxious signs and symptoms in major depression. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199300840-00013
535. Tong, G., Groom, K. N., Ward, L., & Naeem, M. Y. (2021). “This Is Not the Original Timeline”: A Case Report of an Extended Dissociative Episode in a Healthy Young Male Accompanied with Severe Decline in Mental State. Case Reports in Psychiatry. https://doi.org/10.1155/2021/6619579
536. Tonkin, A., & Frewin, D. B. (2013). Drugs, chemicals, and toxins that alter autonomic function. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198566342.003.0073
537. Torre, J. L. F., Pérez, R. G., & Zarzosa, M. V. (2003). Estado epiléptico no convulsivo. Revista de Neurología. https://doi.org/10.33588/rn.3708.2003146
538. Toudou‐Daouda, M., Assadeck, H., Obenda, N. S., & Souirti, Z. (2017). Céphalées épileptiques isolées : revue de la littérature. Isolated epileptic headache : review. African & Middle East Epilepsy Journal.
539. Trahan, M. A., Kahng, S., Donaldson, J. M., & McNabney, M. (2013). “Just Make it Stop”: A Case Report of Excessive Crying in an Individual with Dementia. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.12339
540. Trenité, D. K. (2012). Provoked and reflex seizures: Surprising or common?. Epilepsia. https://doi.org/10.1111/j.1528-1167.2012.03620.x
541. Trevisan, L., Boutros, N. N., Petrakis, I. L., & Krystal, J. H. (1998). Complications of alcohol withdrawal: pathophysiological insights.. PubMed.
542. Trivedi, K., Kataria, L., & Patel, D. (2020). A COMPARATIVE STUDY EVALUATING THE DEPRESSIVE SYMPTOMS AND FUNCTIONAL OUTCOME IN PATIENTS TREATED WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS V/S SEROTONIN–NOREPINEPHRINE REUPTAKE INHIBITORS AS ANTIDEPRESSANT AGENTS IN MAJOR DEPRESSIVE DISORDER.
543. Tso, I. F., Chun, J., & Deldin, P. J. (2010). Schizoaffective Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0818
544. Ubaidi, B. A. A. (2017). Integrate of Spiritual Needs into Patient Care. Journal of Family Medicine and Disease Prevention. https://doi.org/10.23937/2469-5793/1510056
545. Uhde, T. W., & Roy-Byrne, P. P. (1988). Exogenous factors in panic disorder: clinical and research implications.. PubMed.
546. Unknown (2007). Alcohol withdrawal syndrome: how to predict, prevent, diagnose and treat it.. PubMed.
547. Unknown (2007). Dementias and Behavioral Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-078-2_3
548. Unknown (2007). Hyperventilation syndrome. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199202447.003.0022
549. Unknown (2007). Neoplasms of the Nervous System and Related Topics. CRC Press eBooks. https://doi.org/10.1201/b14430-21
550. Unknown (2007). Part III: Insomnia and Circadian Dysrhythmias. CRC Press eBooks. https://doi.org/10.3109/9781420014693-8
551. Unknown (2015). Alcohol withdrawal syndrome: preventive measures.. PubMed.
552. Unknown (2016). Decision letter: Postictal behavioural impairments are due to a severe prolonged hypoperfusion/hypoxia event that is COX-2 dependent. https://doi.org/10.7554/elife.19352.020
553. Valdez, J. M. (2013). [Status epilepticus in childhood].. PubMed.
554. Valman, H. B. (1989). The first year of life. Convulsions in the older infant.. BMJ. https://doi.org/10.1136/bmj.299.6711.1331
555. Vandriel, S. M., McCluskey, L., Elman, L., Boller, A., & Grossman, M. (2014). ALS-Plus Syndrome: Non-motor Features in a Large ALS Cohort (S36.001). Neurology. https://doi.org/10.1212/wnl.82.10_supplement.s36.001
556. Varelas, P. N., & Jones, M. (2017). Antiepileptic Drugs in the Neurosurgical Intensive Care. Current Pharmaceutical Design. https://doi.org/10.2174/1381612823666171030150437
557. Vasconcelos, L. P. B., Gandini, J., Teixeira, A., & Manto, M. (2022). Movement Disorders Associated With Stimulants and Other Drugs of Abuse. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197574317.003.0009
558. Velasco-Rey, M. C., Sánchez-Muñoz, M., Lopez, M., Trujillo-Borrego, A., & Sánchez-Bonome, L. (2012). Psychotic depression induced by Obstructive Sleep Apnoea Syndrome (OSAS): a case reported.. PubMed.
559. Vendruscolo, L. F., & Koob, G. F. (2019). Alcohol Dependence Conceptualized as a Stress Disorder. https://doi.org/10.1093/oxfordhb/9780190681777.013.9
560. Venkateswarlu, N. (2016). A Short Note on Alcohol Withdrawal Syndrome. Research and reviews : journal of pharmacology and toxicological studies.
561. Venkateswarlu, N. (2016). Research and Reviews: Journal of Pharmacology and Toxicological Studies A Short Note on Alcohol Withdrawal Syndrome.
562. Vernier, L., Rocha, B., Razzolini, D., Bartz, D., & Vargas, G. (2014). Reports of Complaints with Tinnitus Patients: A Qualitative Study. International Archives of Otorhinolaryngology. https://doi.org/10.1055/s-0034-1389005
563. Viader, F. (2019). L’ictus amnésique idiopathique : un syndrome amnésique exemplaire. Revue de neuropsychologie. https://doi.org/10.3917/rne.111.0070
564. Vilibić, M., Jukić, V., Vidović, A., & Brečić, P. (2013). Cobalamin deficiency manifested with seizures, mood oscillations, psychotic features and reversible dementia in the absence of typical neurologic and hematologic signs and symptoms: a case report.. PubMed.
565. Vitiello, B., Zuddas, A., & Masi, G. (2006). Pharmacologic treatment of children and adolescents with attention deficit hyperactivity disorder. CRC Press eBooks. https://doi.org/10.1201/b14454-11
566. Wakil, L., Meltzer‐Brody, S., & Girdler, S. S. (2012). Premenstrual Dysphoric Disorder: How to Alleviate Her Suffering; Accurate Diagnosis, Tailored Treatments Can Greatly Improve Women's Quality of Life. Current psychiatry.
567. Walterscheid, B., Eshak, N., & Nugent, K. (2021). Altered mental status in a patient with psychiatric history: Medication noncompliance or medical etiology?. Journal of Investigative Medicine.
568. Wand, G. S. (2008). The influence of stress on the transition from drug use to addiction.. PubMed.
569. Wang, D., Boo, Y. Y. A., Goh, K. C., & Goveas, R. (2022). Psychiatric causes of behavioural change in adults less than 65 years old. Singapore Medical Journal. https://doi.org/10.4103/singaporemedj.smj-2021-305
570. Ward, B. K., Berg, R. V. D., Rompaey, V. V., Bisdorff, A., Hullar, T. E., Welgampola, M. S., & Carey, J. P. (2021). Superior semicircular canal dehiscence syndrome: Diagnostic criteria consensus document of the committee for the classification of vestibular disorders of the Bárány Society. Journal of Vestibular Research. https://doi.org/10.3233/ves-200004
571. Ware, W. A., Bonagura, J. D., & Scansen, B. A. (2021). Exercise Intolerance. CRC Press eBooks. https://doi.org/10.1201/9780429186639-9
572. Weisholtz, D. S., & Dworetzky, B. A. (2014). Epilepsy and Psychosis.
573. Weiss, B., Clarkson, T. W., & Simon, W. (2002). Silent latency periods in methylmercury poisoning and in neurodegenerative disease.. Environmental Health Perspectives. https://doi.org/10.1289/ehp.02110s5851
574. Williams, A. M. (2011). OP.02 Restless legs, periodic limb movements and breathing problems. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2011-300504.2
575. Wilson, B. A. (1998). Patients and their Problems. https://doi.org/10.1093/oso/9780195065985.003.0001
576. Winner, J. G. (2012). Overwhelmed by Side Effects. Current psychiatry.
577. Wright, S. L. (2020). Benzodiazepine Withdrawal. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197517277.003.0008
578. Wulandari, A., Kusuma, M. D., & Pancarani, R. (2023). Bipolar disorder - difficulties in managing emotional ups and down in an entertainer life: a case report. https://doi.org/10.35990/amhs.v1n3.p137-143
579. Wyatt, J. P., Illingworth, R. N., Graham, C. A., Hogg, K., Clancy, M., & Robertson, C. E. (2012). Environmental emergencies. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199589562.003.0006
580. Xiao, J., Chan, C. W., & Chow, K. M. (2019). LIVING WITH DIGNITY AMONG CHINESE CANCER PATIENTS UNDERGOING CHEMOTHERAPY: A QUALITATIVE STUDY. https://doi.org/10.26226/morressier.5cdbe0ab618793e647b12cfb
581. Yarlagadda, A. R., Brown, A. B., & Clayton, A. H. (2007). Onset of Obstructive Sleep Apnea After Initiation of Psychotropic Agents. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0611h
582. Yee, B. J., Liu, P. Y., Phillips, C. L., & Grunstein, R. R. (2013). Neuroendocrine aspects of sleep apnea. CRC Press eBooks. https://doi.org/10.3109/9781420020885-16
583. Yennurajalingam, S., & Bruera, É. (2021). Fatigue. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198821328.003.0066
584. Yersin, B. (1999). [Ambulatory management of alcohol withdrawal syndrome].. PubMed.
585. Young, W. B., Packard, R. C., & Katsarava, Z. (2007). Headaches Associated with Head Trauma. https://doi.org/10.1093/oso/9780195326567.003.0016
586. Yung, A. R. (2011). Risk, Disorder and Diagnosis. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.3109/00048674.2011.614926
587. Zutshi, A., Math, S. B., & Reddy, Y. C. J. (2007). Escitalopram in Obsessive-Compulsive Disorder. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0611c
588. Šumarac-Dumanović, M., Micić, D., Macut, Đ. P., Kendereški, A., Zorić, S., Cvijović, G., & Pejković, D. (2002). Hipoglikemijski sindromi - dijagnostički i terapijski pristup i prikaz dva slučaja. ABC - časopis urgentne medicine.